title: PBMC, TCRgd Vd2, HTO, batch 2

type: SRA

city: Freiburg

first: Jakob

last: Arnold

address: Breisacher Str. 66

country: Germany

institute: Uniklinik Freiburg

description:
Library name: PBMC_Vd2_10X5P_HTO_2
HTO info: HD donors: Hu.Hashtag_1, Hu.Hashtag_2; UC donors: Hu.Hashtag_3, Hu.Hashtag_4, Hu.Hashtag_5, Hu.Hashtag_6

library_source: other

data_processing:
Sequencing reads from FLASH-Seq were pre-processed using BBDUK from the BBMAP suite (v39.06) for trimming and Trimmomatic PE (CROP:75 MINLEN:50, v0.39) for cropping. Cleaned reads were aligned to the Gencode hg38 reference genome (v46) using the STAR aligner (v2.7.11b) with parameters --limitSjdbInsertNsj 2000000 and --outFilterIntronMotifs RemoveNoncanonicalUnannotated. Primary alignments were retained using SAMtools (v1.13). Gene expression was quantified with featureCounts (v2.0.6) using the parameters -p -t exon -g gene_name --fracOverlap 0.25 and the Gencode primary assembly annotation (v46). For V(D)J and C (V(D)JC) repertoire analysis, raw sequencing reads were processed with MiXCR (v4.6.0) using its Smart-seq2 wrapper function and the built-in RepSeq.io reference library (v4.0)39. Sequencing reads from the 10x Genomics platform were processed using CellRanger’s (v8.0.0) multi pipeline to quantify gene expression and antibody-derived hashtag counts. Alignment was performed with the pre-built hg38 reference (v2020-A). TCR libraries from 10x Genomics sequencing were analyzed with MiXCR’s analyze 10x-sc-xcr-vdj wrapper function, leveraging the built-in reference library for annotation.
Assembly: PBMC (10x Genomics): GENCODE v32; colon (FLASHseq): GENCODE v46
Supplementary files format and content: FLASH-Seq output files: counts.mtx.gz, cells.tsv.gz and genes.tsv.gz; 10x Genomics output files: barcodes.tsv.gz, features.tsv.gz, matrix.mtx.gz and MiXCR output files: clones.tsv.gz
Library strategy: CITE-seq

molecule: protein

source_name: PBMC

extract_protocol:
For isolation of intestinal lymphocytes from biopsies, samples were mechanically homogenized using a 70 µm cell strainer, washed with PBS and cryopreserved in 90% FBS and 10% DMSO. On the day of the experiment, frozen cells were thawed in RPMI-1640, centrifuged at 400×g for 5 minutes, and washed once with PBS. Cells were stained with a viability stain (BD Horizon, Fixable Viability Stain 780), antibodies against CD3E (PE/Cynanine7, SK7, BioLegend) and TCR γδ (PE, REA591, Miltenyi Biotec). Viable TCRγδ+ T cells were sorted into 384-well plates using MoFlo Astrios EQ (Beckman Coulter). For blood samples, those collected in EDTA tubes and were diluted 1:1 with phosphate-buffered saline (PBS) and overlaid in a 2:1 ratio on Ficoll (Ficoll Paque PLUS, GE Healthcare Life Sciences). Samples were centrifuged at 800×g for 20 minutes at room temperature (RT) with no acceleration or braking. The buffy coat was collected, washed with PBS, and centrifuged at 500×g for 10 minutes (RT, maximum acceleration and braking). Cells were cryopreserved at -80°C in freeze in 90% FBS and 10% DMSO. On the day of the experiment, frozen PBMCs were thawed in RPMI-1640, centrifuged at 400×g for 5 minutes, and washed once. Cells were stained with a viability dye, anti-CD3E, anti-TCRγδ, anti-Vδ1, and anti-Vδ2 antibodies. Viable Vδ2+ and Vδ1+ γδ T cells were sorted into BSA-coated 1.5 mL Eppendorf tubes using a MoFlo Astrios EQ sorter (Beckman Coulter).
cDNA synthesis and library preparation of sorted gut γδ T cells were conducted using the FLASH-Seq protocol as described previously (PMID: 35637419; PMCID: PMC9546769). Library concentration and size were assessed before normalization to 1.9 nM. Sequencing was performed on an Illumina NextSeq550 High Output flow cell (75-8-8-75) with a target of approximately 125,000 reads per cell. Single-cell RNA sequencing of blood-derived Vd1+ and Vd2+ T cells was performed using 10x Genomics with feature barcoding technology, allowing for multiplexing of cell samples from different donors to reduce costs and minimize technical variability. Hashtag oligonucleotides were obtained pre-conjugated in TotalSeq-C (5′ chemistry) formats from BioLegend. Cells were stained with barcoded antibodies during the staining step before FACS sorting. Antibodies were used at a concentration of 1 µg per million cells, as recommended by the manufacturer (BioLegend) for flow cytometry applications. After staining, cells were washed twice in PBS containing 2% BSA and 0.01% Tween 20, followed by centrifugation (400×g, 5 minutes, 4 °C) and supernatant exchange. After the final wash, cells were resuspended in PBS, filtered through 40-μm cell strainers, and prepared for sorting. Sorted Vd1+ and Vd2+ T cells were processed using the 10x Genomics single-cell 5′ V(D)J workflow according to the manufacturer’s instructions. Single-cell TCR libraries were generated using the following primers: First PCR: 1 μM forward primer (5′-GATCTACACTCTTTCCCTACACGACGC-3′) and 1 μM of each reverse primer (5′-ATCCCA GAATCGTGTTGCTC-3′, and 5′- CCCACTGGGAGAGATGACAA-3′). Second PCR: 1 μM forward primer (5′-GATCTACACTCTTTCCCTACACGACGC -3′) and 1 μM of each reverse primer (5′-GGGGAAACATCTGCATCAAG-3′ and 5′-GACAAAAACGGATGGTTTGG-3′). Libraries were pooled in appropriate quantities to achieve the desired sequencing depth, following 10x Genomics guidelines, and sequenced using NovaSeq 6000.

value: PBMC

tag: cell type

value: TCRgd Vd2

tag: library type

value: HTO

tag: batch


title: PBMC, TCRgd Vd2, TCR, batch 2

status: Public on Jan 13 2026

description: Library name: PBMC_Vd2_10X5P_TCR_2

library_source: transcriptomic

data_processing:
Sequencing reads from FLASH-Seq were pre-processed using BBDUK from the BBMAP suite (v39.06) for trimming and Trimmomatic PE (CROP:75 MINLEN:50, v0.39) for cropping. Cleaned reads were aligned to the Gencode hg38 reference genome (v46) using the STAR aligner (v2.7.11b) with parameters --limitSjdbInsertNsj 2000000 and --outFilterIntronMotifs RemoveNoncanonicalUnannotated. Primary alignments were retained using SAMtools (v1.13). Gene expression was quantified with featureCounts (v2.0.6) using the parameters -p -t exon -g gene_name --fracOverlap 0.25 and the Gencode primary assembly annotation (v46). For V(D)J and C (V(D)JC) repertoire analysis, raw sequencing reads were processed with MiXCR (v4.6.0) using its Smart-seq2 wrapper function and the built-in RepSeq.io reference library (v4.0)39. Sequencing reads from the 10x Genomics platform were processed using CellRanger’s (v8.0.0) multi pipeline to quantify gene expression and antibody-derived hashtag counts. Alignment was performed with the pre-built hg38 reference (v2020-A). TCR libraries from 10x Genomics sequencing were analyzed with MiXCR’s analyze 10x-sc-xcr-vdj wrapper function, leveraging the built-in reference library for annotation.
Assembly: PBMC (10x Genomics): GENCODE v32; colon (FLASHseq): GENCODE v46
Supplementary files format and content: FLASH-Seq output files: counts.mtx.gz, cells.tsv.gz and genes.tsv.gz; 10x Genomics output files: barcodes.tsv.gz, features.tsv.gz, matrix.mtx.gz and MiXCR output files: clones.tsv.gz
Library strategy: TCR-Seq

molecule: polyA RNA

organism: Homo sapiens

tag: tissue

value: TCR


title: SJWLM018884_203239900211_R06C01

type: genomic

city: Memphis

first: Zhaoming

last: Wang

address: 262 Danny Thomas Place

country: USA

institute: St. Jude Children's Research Hospital

description:
203239900211_R06C01
blood from survivor of childhood cancer and control

hyb_protocol: Bisulfite-converted DNA was processed by following the Illumina Infinium Methylation Assay protocol for hybridization to MethylationEPIC BeadChips.

scan_protocol: Scanning used the Illumina HiScan system followed the Illumina Infinium Methylation Assay protocol.

data_processing: Genome-wide DNAm data were generated using Illumina Infinium MethylationEPIC BeadChip v1 (Illumina, San Diego, CA, USA), with DNA extracted from peripheral blood mononuclear cells (PBMCs) or saliva. Preprocessing was conducted using the minfi package in R, following established quality control procedures including a detection p-value ≤ 0.01. CpGs were excluded if they were located on sex chromosomes, contained single nucleotide polymorphisms (SNPs), or were previously identified as cross-reactive or non-specific. Quantile normalization was applied at the probe level to ensure comparability across samples.

label: Cy5 and Cy3

molecule: genomic DNA

source_name: genomic DNA derived from blood samples from survivor of childhood cancer and community control

label_protocol: Standard Illumina Protocol

extract_protocol: Genomic DNA (250 ng per sample) were treated with bisulfite using the Zymo EZ DNA Methylation Kit under the following thermos-cycling conditions: 16 cycles: 95 degrees Celsius for 30 sec, 50 degrees Celsius for 1 hour. Following bisulfite treatment, DNA samples were desulphonated, column purified, then eluted using 12 µl of elution buffer (Zymo Research Corp.). Treating DNA with sodium bisulfite selectively converts cytosine to uracil but preserves 5-methylcytosine, which is immune from deamination.

value: peripheral blood mononuclear cells

tag: age

tag: Sex

value: female

tag: group

value: cancer survivor

tag: age at cancer diagnosis

tag: diagnostic group

value: Wilms tumor

tag: average dose to whole heart, cgy

tag: race group

value: Black

tag: base line visit start date

tag: base line visit finish

tag: age at death


title: SJWLM018881_203239900211_R07C01

description:
203239900211_R07C01
blood from survivor of childhood cancer and control

value: male

value: White


title: PBMC, TCRgd Vd2, GEX, batch 2

description: Library name: PBMC_Vd2_10X5P_GEX_2

library_source: transcriptomic single cell

data_processing:
Sequencing reads from FLASH-Seq were pre-processed using BBDUK from the BBMAP suite (v39.06) for trimming and Trimmomatic PE (CROP:75 MINLEN:50, v0.39) for cropping. Cleaned reads were aligned to the Gencode hg38 reference genome (v46) using the STAR aligner (v2.7.11b) with parameters --limitSjdbInsertNsj 2000000 and --outFilterIntronMotifs RemoveNoncanonicalUnannotated. Primary alignments were retained using SAMtools (v1.13). Gene expression was quantified with featureCounts (v2.0.6) using the parameters -p -t exon -g gene_name --fracOverlap 0.25 and the Gencode primary assembly annotation (v46). For V(D)J and C (V(D)JC) repertoire analysis, raw sequencing reads were processed with MiXCR (v4.6.0) using its Smart-seq2 wrapper function and the built-in RepSeq.io reference library (v4.0)39. Sequencing reads from the 10x Genomics platform were processed using CellRanger’s (v8.0.0) multi pipeline to quantify gene expression and antibody-derived hashtag counts. Alignment was performed with the pre-built hg38 reference (v2020-A). TCR libraries from 10x Genomics sequencing were analyzed with MiXCR’s analyze 10x-sc-xcr-vdj wrapper function, leveraging the built-in reference library for annotation.
Assembly: PBMC (10x Genomics): GENCODE v32; colon (FLASHseq): GENCODE v46
Supplementary files format and content: FLASH-Seq output files: counts.mtx.gz, cells.tsv.gz and genes.tsv.gz; 10x Genomics output files: barcodes.tsv.gz, features.tsv.gz, matrix.mtx.gz and MiXCR output files: clones.tsv.gz

value: mRNA


title: PBMC, TCRgd Vd2, TCR, batch 1

description: Library name: PBMC_Vd2_10X5P_TCR_1


title: PBMC, TCRgd Vd2, GEX, batch 1

description: Library name: PBMC_Vd2_10X5P_GEX_1


title: PBMC, TCRgd Vd1, HTO, batch 2

description:
Library name: PBMC_Vd1_10X5P_HTO_2
HTO info: HD donors: Hu.Hashtag_1, Hu.Hashtag_2; UC donors: Hu.Hashtag_3, Hu.Hashtag_4, Hu.Hashtag_5, Hu.Hashtag_6

value: TCRgd Vd1


title: SJNHL018790_203244490061_R02C01

description:
203244490061_R02C01
blood from survivor of childhood cancer and control

value: Non-Hodgkin lymphoma


title: PBMC, TCRgd Vd2, HTO, batch 1

description:
Library name: PBMC_Vd2_10X5P_HTO_1
HTO info: HD donors: Hu.Hashtag_1, Hu.Hashtag_2, Hu.Hashtag_3; UC donors: Hu.Hashtag_4, Hu.Hashtag_5, Hu.Hashtag_6


title: RMC82, Pre_NR

city: Houston

first: Pavlos

last: Msaouel

state: Texas

address: 1155 Pressler Street, Unit 1374

department: Genitourinary Medical Oncology

institute: The University of Texas MD Anderson Cancer Center

description:
Library name: RMC82.Pre_NR
10x Genomics

data_processing:
The fastq files from single-cell sequencing were preprocessed using Cell Ranger software (version 7.1.0)78 with default parameters. Reads were aligned to the human reference genome hg38 (version 2020-A, 10x Genomics) to calculate the expression matrix, which contained the number of unique molecular identifiers (UMIs) for every cell and gene. To ensure high-quality data for downstream analysis, careful selection of samples and cells was performed. Cells with gene expression of fewer than 500 genes were removed to eliminate cell debris, empty drops, and low-quality cells. Cells with a mitochondrial versus endogenous genes expression ratio exceeding 15% were also discarded. Additionally, genes expressed in fewer than 3 cells were excluded from the expression matrix. Subsequently, the Seurat package79 was used for data preprocessing. The raw expression matrix was log2 transformed with the NormalizeData function, scaled with the ScaleData function using default parameters, and the top 2000 genes with the highest standardized variance were identified using the FindVariableFeatures function. Principal component analysis (PCA) was performed using the RunPCA function with default parameters.
Assembly: hg38
Supplementary files format and content: Tab-separated values files and matrix files

molecule: total RNA

source_name: Lymph node

extract_protocol:
A total of 15 biopsy specimens were minced to < 1 mm fragments, placed in 2 mL Eppendorf tubes containing Liberase TM (0.1 mg/mL) and DNase I (0.2 mg/mL; MilliporeSigma) in RPMI-1640/0.1 % BSA, and incubated at 37 °C for 15 min with gentle rotation. The resulting suspension was passed through 70 µm strainers, pelleted, and treated with ACK red-blood-cell lysis buffer (ThermoFisher, #A1049201). Cell viability was assessed by trypan-blue exclusion, and only samples with > 60 % viability proceeded to Chromium iX (10x Genomics) for generation of 5′ v2 gel beads-in-emulsions (GEMs).
The barcoded cDNA was then purified, amplified, and converted into 10x single-cell RNA-seq libraries, quantified on a Bioanalyzer 2100 (Agilent), and sequenced on a NovaSeq 6000 at ~50,000 reads per cell following the manufacturer’s guidelines.

value: Lymph node

tag: subject status

value: patients with RMC

tag: subject id

tag: time point


title: RMC75, EOT

description:
Library name: RMC75.EOT
10x Genomics

source_name: Kidney

value: Kidney

value: EOT


title: RMC73, Pre_R

description:
Library name: RMC73.Pre_R
10x Genomics

source_name: Liver

value: Liver


title: PBMC, TCRgd Vd1, GEX, batch 2

description: Library name: PBMC_Vd1_10X5P_GEX_2

value: PBMC

tag: cell type


title: PBMC, TCRgd Vd1, TCR, batch 1

description: Library name: PBMC_Vd1_10X5P_TCR_1

tag: library type

value: TCR


title: PBMC, TCRgd Vd1, HTO, batch 1

description:
Library name: PBMC_Vd1_10X5P_HTO_1
HTO info: HD donors: Hu.Hashtag_1, Hu.Hashtag_2, Hu.Hashtag_3; UC donors: Hu.Hashtag_4, Hu.Hashtag_5, Hu.Hashtag_6

value: HTO

tag: batch


title: PBMC, TCRgd Vd1, TCR, batch 2

description: Library name: PBMC_Vd1_10X5P_TCR_2

tag: tissue


title: RMC75, Pre_NR

description:
Library name: RMC75.Pre_NR
10x Genomics


title: RMC71, Pre_R

description:
Library name: RMC71.Pre_R
10x Genomics


title: RMC57, EOT

description:
Library name: RMC57.EOT
10x Genomics


title: RMC73, Post

description:
Library name: RMC73.Post
10x Genomics

source_name: Lung

value: Lung

value: Post


title: ChIPseq_Erlotinib_EGF_Input_biolRep2

first: Wojciech

last: Rosikiewicz

state: TN

department: Center for Applied Bioinformatics

institute: St. Jude Childrens Research Hospital

description:
Library name: 2282786_Erlotinib_EGF_Input_BR2
Spike-in: drosophila melanogaster

library_source: genomic

data_processing:
Raw reads in fastq format were processed with Trim-Galore tool (v0.4.4)
Reads were mapped to human-fly hybrid reference genome with bwa sampe (v0.7.17-r1198) with -K flag set to 10000000; and reads mapping to human reference were further extracted.
Duplicated reads were marked with bamsormadup tool from biobambam2 (v2.0.87) and Cross-Correlation analysis was conducted with SPP (v1.11)
MACS2 program  was used to call peaks in narrow mode, with -nomodel -q 0.05 flags (high confidence peaks), using matched input samples as control for the peak calling step.
Finally, bedtools (v2.24.0) was used to filter out all the peaks overlapping with ENCODE's blacklist regions.
Assembly: hg38 (GRCh38.p12), dm6
Supplementary files format and content: bigwig
Supplementary files format and content: narrowPeak

source_name: cell line

growth_protocol: RPMI + 15% FBS + anti/anti. BRD4 samples were grown -anti/anti

extract_protocol:
Chromatin was immunoprecipitated using the standard Covaris protocol and purified on silica columns. Samples with Drosophila melanogaster spike-in were processed using a common ChIP protocol and purified using phenol-chloroform extraction
Libraries were constructed using standard Illumina protocols

treatment_protocol: Samples were treated for 24 hours using indicated compounds

value: Rhabdomyosarcoma (RD) cells

tag: chip antibody

tag: treatment

value: Erlotinib (Thermo Fisher SLM2156) + 100mg/ul EGF (Sigma E9644)


title: RMC47, Post

description:
Library name: RMC47.Post
10x Genomics


title: ChIPseq_Erlotinib_Input_biolRep2

description:
Library name: 2282785_Erlotinib_Input_BR2
Spike-in: drosophila melanogaster

value: Erlotinib (Thermo Fisher SLM2156)


title: ChIPseq_EGF_Input_biolRep2

description:
Library name: 2282784_EGF_Input_BR2
Spike-in: drosophila melanogaster

value: DMSO (Sigma) + 100ng/ml EGF (Sigma E9644) treated cells


title: PBMC, TCRgd Vd1,GEX, batch 1

description: Library name: PBMC_Vd1_10X5P_GEX_1

value: mRNA


title: RMC66, Pre_NR

description:
Library name: RMC66.Pre_NR
10x Genomics


title: RMC71, Post

description:
Library name: RMC71.Post
10x Genomics


title: ChIPseq_DMSO_Input_biolRep2

description:
Library name: 2282783_DMSO_Input_BR2
Spike-in: drosophila melanogaster

value: DMSO (Sigma)


title: ChIPseq_Erlotinib_PolII_biolRep2

description:
Library name: 2282773_Erlotinib_PolII_BR2
Spike-in: drosophila melanogaster

value: RNA Pol II (Active Motif# 61667)


title: RMC57, Pre_NR

description:
Library name: RMC57.Pre_NR
10x Genomics


title: RMC61, Pre_NR

description:
Library name: RMC61.Pre_NR
10x Genomics


title: RMC56, Pre_R

description:
Library name: RMC56.Pre_R
10x Genomics


title: RMC49, Pre_NR

description:
Library name: RMC49.Pre_NR
10x Genomics

value: Lymph node


title: RMC46, Pre_NR

description:
Library name: RMC46.Pre_NR
10x Genomics

value: patients with RMC


title: ChIPseq_DMSO_PolII_biolRep1

description:
Library name: 2282755_DMSO_PolII_BR1
Spike-in: drosophila melanogaster


title: Cells from the NRI_ovca batch, GEX

city: Oulu

first: Daniela

last: Ungureanu

address: Aapistie 5A

department: Faculty of Biochemistry and Molecular Medicine

country: Finland

institute: University of Oulu

description:
Library name: NRI_ovca
polyA mRNA
GEX (3' mRNA) library: R1 library contains cell barcode and UMI; R2 contains transcript.

data_processing:
Raw FASTQ file preprocessing was performed using Cell Ranger (version 7.1.0, 10x Genomics) pipelines. Specifically, cellranger mkfastq was used to produce FASTQ (raw sequence data) files and cellranger count to perform alignment, filtering, and UMI counting. Alignment was performed against the GRCh38 (GENCODE v32/Ensembl 98) assembly of the human genome.
Samples were multiplexed using Cell Hashing prior to sequencing, and orignate from three different experimental batches.
Assembly: GRCh38-2020-A (GENCODE v32/Ensembl 98)
Supplementary files format and content: mRNA count matrix; seurat_counts.csv.gz

source_name: Kuramochi

extract_protocol:
Cells were plated in 6-well plates three days prior to scRNA-seq. For scRNA analysis, 10,000 cells were collected for each sample and plated in 96-well plates.
Single-cell gene expression profiling was conducted using the 10x Genomics Chromium Single Cell 3’RNAseq platform (10x Genomics, #CG000317). The Chromium Single Cell 3’RNAseq workflow, including library preparation, were done using the Chromium Next GEM Single Cell 3’ Gene expression version 3.1 Dual Index chemistry with Feature Barcoding technology. Sequencing of libraries was performed on an Illumina NovaSeq 6000 system (Illumina).

treatment_protocol: Resistant cell lines were established by gradually increasing PTX or ADA concentrations based on the IC50 of each parental cell line. Cells were allowed to rest if extensive cell death was detected, and drug amount was increased once the cells showed recovery. The resistance was also tested after cryopreservation and thawing. To maintain the resistant phenotype, cells were cultured with the maximum concentration of drug added to the culture media. For short term samples, parental JHOS2, Kuramochi and Ovsaho were treated with 500 nM of ADA (JHOS2, Kuramochi, and Ovsaho) or 100 nM of PTX (JHOS2 and COV318), to get 72h treatment of the drugs.

tag: cell line

value: Kuramochi

value: untreated


title: ChIPseq_EGF_PolII_biolRep2

description:
Library name: 2282772_EGF_PolII_BR2
Spike-in: drosophila melanogaster


title: Cells from the Batch2 batch, GEX

description:
Library name: Batch2
polyA mRNA
GEX (3' mRNA) library: R1 library contains cell barcode and UMI; R2 contains transcript.

source_name: COV318, JHOS2, Kuramochi, Ovsaho

value: COV318, JHOS2, Kuramochi, Ovsaho

value: mixed sample (untreated, treated)


title: ChIPseq_DMSO_Input_biolRep1

description:
Library name: 2282767_DMSO_Input_BR1
Spike-in: drosophila melanogaster


title: ChIPseq_Erlotinib_Input_biolRep1

description:
Library name: 2282769_Erlotinib_Input_BR1
Spike-in: drosophila melanogaster


title: CRISPRoff_CXCR4_3d_BFP+++

city: Solna

first: Maria

last: Needhamsen

address: Solnavagen 1

department: Clinical Neuroscience

country: Sweden

institute: Karolinska Institutet

description:
Library name: P25155_1093
TMS_CXCR4_Pannel
P25155_1093_S93

data_processing:
Data were analyzed using the QIAGEN CLC Genomics Workbench (QIAGEN, Aarhus, Denmark) and if the coverage of the context was less than 10X, we assigned methylation values to "missing".
Assembly: hg38
Supplementary files format and content: Comma-delimited file includes Methylation level

growth_protocol: Human embryonic kidney HEK293T cells were maintained in Dulbecco’s Modified Eagle Medium (Sigma Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Sigma Aldrich), 4 mM L-glutamine (Sigma Aldrich), 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma Aldrich). Cells were incubated at 37◦C in a humidified 5% CO2-containing atmosphere

extract_protocol:
To enrich the EGFP+ cells, FACS sorting was performed after 72 h and the sorted cells were subjected directly for DNA, RNA and protein extraction using AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Venlo, Netherlands).
we employed QIAseq Targeted Methyl Panel technology. The primer panels to enrich these regions were designed by QIAGEN (Hilden, Germany) both for the BACH2 (258 CpGs, 33 loci, 22,768 bp) and CXCR4 (212 CpGs, 13 loci, 10,871 bp) gRNAs (Supple. Table 2). Briefly, 110 ng DNA was bisulfite converted using EpiTect Fast Bisulfite Conversion Kit according to the manufacturer’s instructions. Converted DNA fragments were attached to unique molecular identifier (UMI) and libraries were created using the QIAseq Targeted Methyl Panel protocol and were amplified for 18 cycles.

treatment_protocol: HEK293T cells were transfected using Lipofectamine 3000 Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. Briefly, cells were seeded in 6 well plates and were transfected the day after at around 80% of confluency. The transfection cocktail was prepared as follows: 4µg of the plasmid DNA, 5 µl Lipofectamine™ 3000 Reagent, 5 µl P3000™ Reagent (2 µL/µg DNA) and Opti-MEM™ Medium (Invitrogen).

value: epithelial-like cell


title: ChIPseq_DMSO_PolII_biolRep2

description:
Library name: 2282771_DMSO_PolII_BR2
Spike-in: drosophila melanogaster


title: ChIPseq_Erlotinib_EGF_Input_biolRep1

description:
Library name: 2282770_Erlotinib_EGF_Input_BR1
Spike-in: drosophila melanogaster


title: ChIPseq_EGF_PolII_biolRep1

description:
Library name: 2282756_EGF_PolII_BR1
Spike-in: drosophila melanogaster


title: ChIPseq_Erlotinib_PolII_biolRep1

description:
Library name: 2282757_Erlotinib_PolII_BR1
Spike-in: drosophila melanogaster

value: Erlotinib (Thermo Fisher)


title: 3A_NTC_21d

description:
Library name: P25155_1090
TMS_BACH2_g8_Pannel
P25155_1090_S90


title: ChIPseq_EGF_Input_biolRep1

description:
Library name: 2282768_EGF_Input_BR1
Spike-in: drosophila melanogaster


title: ChIPseq_Erlotinib_EGF_PolII_biolRep1

description:
Library name: 2282758_Erlotinib_EGF_PolII_BR1
Spike-in: drosophila melanogaster

value: Erlotinib (Thermo Fisher) + 100ng/ml EGF (Sigma E9644)


title: ChIPseq_Erlotinib_EGF_PolII_biolRep2

description:
Library name: 2282774_Erlotinib_EGF_PolII_BR2
Spike-in: drosophila melanogaster


title: Cells from the CellResist batch, GEX

description:
Library name: CellResist
polyA mRNA
GEX (3' mRNA) library: R1 library contains cell barcode and UMI; R2 contains transcript.

value: CellResist


title: CRISPRoff_NTC_CXCR4_3d_BFP+++

description:
Library name: P25155_1094
TMS_CXCR4_Pannel
P25155_1094_S94


title: CRISPRoff_CXCR4_3d_BFP++

description:
Library name: P25155_1095
TMS_CXCR4_Pannel
P25155_1095_S95


title: mut3A_NTC_21d

description:
Library name: P25155_1091
TMS_BACH2_g8_Pannel
P25155_1091_S91


title: Non-transfected_21d

description:
Library name: P25155_1084
TMS_BACH2_g8_Pannel
P25155_1084_S84


title: 3A_BACH2_g8_21d

description:
Library name: P25155_1080
TMS_BACH2_g8_Pannel
P25155_1080_S80


title: 3A3L_BACH2_g8_21d

description:
Library name: P25155_1076
TMS_BACH2_g8_Pannel
P25155_1076_S76


title: 3A_KRAB_NTC_21d

description:
Library name: P25155_1087
TMS_BACH2_g8_Pannel
P25155_1087_S87


title: CRISPRoff_NTC_14d

description:
Library name: P25155_1075
TMS_BACH2_g8_Pannel
P25155_1075_S75


title: 3A_KRAB_BACH2_g8_21d

description:
Library name: P25155_1077
TMS_BACH2_g8_Pannel
P25155_1077_S77


title: SunTag_BACH2_g8_14d

description:
Library name: P25155_1070
TMS_BACH2_g8_Pannel
P25155_1070_S70


title: CRISPRoff_NTC_21d

description:
Library name: P25155_1092
TMS_BACH2_g8_Pannel
P25155_1092_S92


title: CRISPRoff_NTC_3d

description:
Library name: P25155_1068
TMS_BACH2_g8_Pannel
P25155_1068_S68


title: mut3A_NTC_3d_

description:
Library name: P25155_1067
TMS_BACH2_g8_Pannel
P25155_1067_S67


title: M.SssI_NTC_21d

description:
Library name: P25155_1088
TMS_BACH2_g8_Pannel
P25155_1088_S88


title: M.SssI_NTC_3d

description:
Library name: P25155_1064
TMS_BACH2_g8_Pannel
P25155_1064_S64


title: 3A3A_NTC_3d

description:
Library name: P25155_1061
TMS_BACH2_g8_Pannel
P25155_1061_S61


title: 3A3L_NTC_3d

description:
Library name: P25155_1062
TMS_BACH2_g8_Pannel
P25155_1062_S62


title: d3A_BACH2_g8_3d

description:
Library name: P25155_1059
TMS_BACH2_g8_Pannel
P25155_1059_S59


title: SunTag_NTC_21d

description:
Library name: P25155_1089
TMS_BACH2_g8_Pannel
P25155_1089_S89


title: M.SssI_NTC_14d

description:
Library name: P25155_1055
TMS_BACH2_g8_Pannel
P25155_1055_S55


title: 3A3L_NTC_21d

description:
Library name: P25155_1086
TMS_BACH2_g8_Pannel
P25155_1086_S86


title: 3A_KRAB_NTC_14d

description:
Library name: P25155_1054
TMS_BACH2_g8_Pannel
P25155_1054_S54


title: d3A_BACH2_g8_21d

description:
Library name: P25155_1083
TMS_BACH2_g8_Pannel
P25155_1083_S83


title: d3A_BACH2_g8_14d

description:
Library name: P25155_1050
TMS_BACH2_g8_Pannel
P25155_1050_S50


title: CRISPRoff_BACH2_g8_21d

description:
Library name: P25155_1082
TMS_BACH2_g8_Pannel
P25155_1082_S82


title: mut3A_BACH2_g8_21d

description:
Library name: P25155_1081
TMS_BACH2_g8_Pannel
P25155_1081_S81


title: 3A_BACH2_g8_14d

description:
Library name: P25155_1047
TMS_BACH2_g8_Pannel
P25155_1047_S47


title: 3A3A_NTC_21d

description:
Library name: P25155_1085
TMS_BACH2_g8_Pannel
P25155_1085_S85


title: 3A_KRAB_BACH2_g8_14d

description:
Library name: P25155_1045
TMS_BACH2_g8_Pannel
P25155_1045_S45


title: M.SssI_BACH2_g8_21d

description:
Library name: P25155_1078
TMS_BACH2_g8_Pannel
P25155_1078_S78


title: mut3A_BACH2_g8_14d

description:
Library name: P25155_1048
TMS_BACH2_g8_Pannel
P25155_1048_S48


title: M.SssI_BACH2_g8_14d

description:
Library name: P25155_1046
TMS_BACH2_g8_Pannel
P25155_1046_S46


title: SunTag_BACH2_g8_21d

description:
Library name: P25155_1079
TMS_BACH2_g8_Pannel
P25155_1079_S79


title: mut3A_NTC_14d

description:
Library name: P25155_1074
TMS_BACH2_g8_Pannel
P25155_1074_S74


title: CRISPRoff_NTC_3d_BFP+++

description:
Library name: P25155_1073
TMS_BACH2_g8_Pannel
P25155_1073_S73


title: 3A3L_BACH2_g8_14d

description:
Library name: P25155_1044
TMS_BACH2_g8_Pannel
P25155_1044_S44


title: 3A3A_BACH2_g8_21d

description:
Library name: P25155_1071
TMS_BACH2_g8_Pannel
P25155_1071_S71


title: CRISPRoff_NTC_30d

description:
Library name: P25155_1042
TMS_BACH2_g8_Pannel
P25155_1042_S42


title: 3A3A_BACH2_g8_7d

description:
Library name: P25155_1069
TMS_BACH2_g8_Pannel
P25155_1069_S69


title: SunTag_NTC_3d

description:
Library name: P25155_1065
TMS_BACH2_g8_Pannel
P25155_1065_S65


title: mut3A_NTC_30d

description:
Library name: P25155_1041
TMS_BACH2_g8_Pannel
P25155_1041_S41


title: 3A_KRAB_NTC_3d

description:
Library name: P25155_1063
TMS_BACH2_g8_Pannel
P25155_1063_S63


title: 3A_NTC_3d

description:
Library name: P25155_1066
TMS_BACH2_g8_Pannel
P25155_1066_S66


title: Non-transfected_3d

description:
Library name: P25155_1060
TMS_BACH2_g8_Pannel
P25155_1060_S60


title: CRISPRoff_BACH2_g8_3d

description:
Library name: P25155_1058
TMS_BACH2_g8_Pannel
P25155_1058_S58


title: 3A_NTC_30d

description:
Library name: P25155_1040
TMS_BACH2_g8_Pannel
P25155_1040_S40


title: 3A_NTC_14d

description:
Library name: P25155_1057
TMS_BACH2_g8_Pannel
P25155_1057_S57


title: CRISPRoff_BACH2_g8_3d_BFP+++

description:
Library name: P25155_1072
TMS_BACH2_g8_Pannel
P25155_1072_S72


title: SunTag_NTC_14d

description:
Library name: P25155_1056
TMS_BACH2_g8_Pannel
P25155_1056_S56


title: 3A3L_NTC_14d

description:
Library name: P25155_1053
TMS_BACH2_g8_Pannel
P25155_1053_S53


title: 3A_KRAB_NTC_30d

description:
Library name: P25155_1037
TMS_BACH2_g8_Pannel
P25155_1037_S37


title: d3A_BACH2_g8_30d

description:
Library name: P25155_1033
TMS_BACH2_g8_Pannel
P25155_1033_S33


title: SunTag_NTC_30d

description:
Library name: P25155_1039
TMS_BACH2_g8_Pannel
P25155_1039_S39


title: Non-transfected_30d

description:
Library name: P25155_1034
TMS_BACH2_g8_Pannel
P25155_1034_S34


title: Non-transfected_14d

description:
Library name: P25155_1051
TMS_BACH2_g8_Pannel
P25155_1051_S51


title: 3A_KRAB_BACH2_g8_30d

description:
Library name: P25155_1028
TMS_BACH2_g8_Pannel
P25155_1028_S28


title: 3A_BACH2_g8_30d

description:
Library name: P25155_1031
TMS_BACH2_g8_Pannel
P25155_1031_S31


title: 3A3A_NTC_14d

description:
Library name: P25155_1052
TMS_BACH2_g8_Pannel
P25155_1052_S52


title: M.SssI_NTC_30d

description:
Library name: P25155_1038
TMS_BACH2_g8_Pannel
P25155_1038_S38


title: 3A_NTC_7d

description:
Library name: P25155_1024
TMS_BACH2_g8_Pannel
P25155_1024_S24


title: SunTag_BACH2_g8_30d

description:
Library name: P25155_1030
TMS_BACH2_g8_Pannel
P25155_1030_S30


title: CRISPRoff_BACH2_g8_14d

description:
Library name: P25155_1049
TMS_BACH2_g8_Pannel
P25155_1049_S49


title: CRISPRoff_NTC_7d

description:
Library name: P25155_1026
TMS_BACH2_g8_Pannel
P25155_1026_S26


title: SunTag_NTC_7d

description:
Library name: P25155_1023
TMS_BACH2_g8_Pannel
P25155_1023_S23


title: 3A3L_NTC_7d

description:
Library name: P25155_1020
TMS_BACH2_g8_Pannel
P25155_1020_S20


title: d3A_BACH2_g8_7d

description:
Library name: P25155_1017
TMS_BACH2_g8_Pannel
P25155_1017_S17


title: 3A_KRAB_BACH2_g8_7d

description:
Library name: P25155_1013
TMS_BACH2_g8_Pannel
P25155_1013_S13


title: Non-transfected_7d

description:
Library name: P25155_1018
TMS_BACH2_g8_Pannel
P25155_1018_S18


title: 3A3L_BACH2_g8_7d

description:
Library name: P25155_1012
TMS_BACH2_g8_Pannel
P25155_1012_S12


title: CRISPRoff_BACH2_g8_30d

description:
Library name: P25155_1009
TMS_BACH2_g8_Pannel
P25155_1009_S9


title: M.SssI_BACH2_g8_3d

description:
Library name: P25155_1005
TMS_BACH2_g8_Pannel
P25155_1005_S5


title: 3A3A_BACH2_g8_3d

description:
Library name: P25155_1002
TMS_BACH2_g8_Pannel
P25155_1002_S2


title: 3A3L_BACH2_g8_30d

description:
Library name: P25155_1001
TMS_BACH2_g8_Pannel
P25155_1001_S1


title: 3A3A_NTC_30d

description:
Library name: P25155_1035
TMS_BACH2_g8_Pannel
P25155_1035_S35


title: 3A3L_NTC_30d

description:
Library name: P25155_1036
TMS_BACH2_g8_Pannel
P25155_1036_S36


title: mut3A_BACH2_g8_3d

description:
Library name: P25155_1008
TMS_BACH2_g8_Pannel
P25155_1008_S8


title: 3A3A_BACH2_g8_14d

description:
Library name: P25155_1043
TMS_BACH2_g8_Pannel
P25155_1043_S43


title: mut3A_BACH2_g8_30d

description:
Library name: P25155_1032
TMS_BACH2_g8_Pannel
P25155_1032_S32


title: 3A3A_BACH2_g8_30d

description:
Library name: P25155_1027
TMS_BACH2_g8_Pannel
P25155_1027_S27


title: CRISPRoff_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 17

data_processing:
The RAW RNA sequence files were used to extract the fastq data, which underwent quality control checks using the multiqc software to prepare them for alignment 25. Subsequently, the resulting fastqc files were aligned and annotated using the STAR aligner and Stringtie software 26, incorporating human hg38 refseq information from UCSC. Finally, the analysis of the count matrix was carried out using bash and Python and reads were mapped to the human reference genome hg19 assembly. To filter out low-expressed transcripts, we have considered all the transcripts that have at least one count per transcript across all the samples.  The counts were normalized by CPM using the TMM method and log2 fold change (logFC) was calculated based on the normalized CPM counts. We chose logFC ≥ 2 or logFC < -2 and adjusted p value < 0.05 as the screening criteria.
Assembly: hg19
Supplementary files format and content: Comma-delimited file includes raw counts for each sample
Supplementary files format and content: Comma-delimited file includes CPM values for each sample

extract_protocol:
To enrich the EGFP+ cells, FACS sorting was performed after 72 h and the sorted cells were subjected directly for DNA, RNA and protein extraction using AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Venlo, Netherlands).
The RNA-seq libraries were constructed according to the manufacturer’s protocol using the Illumina® Stranded Total RNA Prep, Ligation with Ribo-Zero Plus (Illumina, CA, USA).

value: DNMT3A_DNMT3L_dCas9_BFP_KRAB (CRISPRoff), non targeted guide RNA (NTC), day3


title: M.SssI_BACH2_g8_30d

description:
Library name: P25155_1029
TMS_BACH2_g8_Pannel
P25155_1029_S29


title: 3A_BACH2_g8_3d

description:
Library name: P25155_1007
TMS_BACH2_g8_Pannel
P25155_1007_S7


title: MSssI_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 13

value: dCas9_M.SssI, non targeted guide RNA (NTC), day3


title: 3A_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 15

value: dCas9_DNMT3A, non targeted guide RNA (NTC), day3


title: M.SssI_NTC_7d

description:
Library name: P25155_1022
TMS_BACH2_g8_Pannel
P25155_1022_S22


title: 3A_KRAB_NTC_7d

description:
Library name: P25155_1021
TMS_BACH2_g8_Pannel
P25155_1021_S21


title: 3A3A_NTC_7d

description:
Library name: P25155_1019
TMS_BACH2_g8_Pannel
P25155_1019_S19


title: 3A3L_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 11

value: dCas9_DNMT3A_DNMT3L, non targeted guide RNA (NTC), day3


title: CRISPRoff_BACH2_g8_7d

description:
Library name: P25155_1016
TMS_BACH2_g8_Pannel
P25155_1016_S16


title: mut3A_BACH2_g8_7d

description:
Library name: P25155_1015
TMS_BACH2_g8_Pannel
P25155_1015_S15


title: SunTag_BACH2_g8_7d

description:
Library name: P25155_1011
TMS_BACH2_g8_Pannel
P25155_1011_S11


title: SunTag_BACH2_g8_3d

description:
Library name: P25155_1006
TMS_BACH2_g8_Pannel
P25155_1006_S6


title: mut3A_NTC_7d

description:
Library name: P25155_1025
TMS_BACH2_g8_Pannel
P25155_1025_S25


title: 3A_KRAB_BACH2_g8_3d

description:
Library name: P25155_1004
TMS_BACH2_g8_Pannel
P25155_1004_S4


title: 3A3L_BACH2_g8_3d

description:
Library name: P25155_1003
TMS_BACH2_g8_Pannel
P25155_1003_S3


title: IP-CTL, untreated, replicate B

city: Montpellier cedex 05

first: Séverine

last: Boulon

address: 141 rue de la Cardonille

country: France

institute: CNRS

description:
Library name: Sample 22
Column name in Raw_Counts_All.txt: vide_un_B3

data_processing:
Image analysis and base calling were realized in real-time using the NovaSeq Control Software and the Real-Time Analysis 3 software respectively (Illumina, San Diego, CA, USA). Demultiplexing and FASTQ files generation were carried out using Illumina’s bcl2fastq software (v2.20.0.422). Adapter sequences were trimmed during this step.
The quality control of raw data and demultiplexed reads was assessed using respectively Illumina’s Sequencing Analysis Viewer (SAV) software and the FastQC (v0.11.9) software from the Babraham Institute.Contaminant screening was performed using FastQ Screen (v0.14.0, Babraham Institute). Quality checks for each samples was summarised using MultiQC software (v1.12).
TopHat2 software (v2.1.1) was used to align the obtained reads on the human genome (hg38 version) and to annotate them according to NBCI database. FeatureCounts (v2.0.3) software was then used to obtain read counts per gene.
Assembly: hg38
Supplementary files format and content: Tab-delimited text file includes raw counts for each Sample

growth_protocol: HCT116 cells were maintained in McCoy media supplemented with 10% fetal bovine serum (FBS) and antibiotics in humified atmosphere with 5% CO2 at 37°C

extract_protocol:
RNA extraction was performed using Qiagen Rneasy kit after immunoprecipitation of RUVBL1/RPAP3 using GFP-Trap or agarose control beads by Chromotek.
RNA libraries were prepared with SMART-seq Stranded kit from Takara Bio according to manufacturer's protocols.

treatment_protocol: Inhibition of translation was induced by 30 minutes of puromycin at 100µg/mL. Inhibition of RUVBL1/2 ATPase activity was induced by 16 hours of CB-6644 at 0,5µM.

tag: genotype

value: RPAP3 GFP-knock-in

tag: rna selection

value: immmunoprecipitated mRNA using uncoupled beads


title: M.SssI_BACH2_g8_7d

description:
Library name: P25155_1010
TMS_BACH2_g8_Pannel
P25155_1010_S10


title: 3A_BACH2_g8_7d

description:
Library name: P25155_1014
TMS_BACH2_g8_Pannel
P25155_1014_S14


title: IP-GFP, untreated, replicate B

description:
Library name: Sample 18
Column name in Raw_Counts_All.txt: gfp_un_B1

value: immmunoprecipitated mRNA using beads coupled to anti-GFP


title: SunTag_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 14

value: dCas9_SunTag_scFv GCN4_DNMT3A, non targeted guide RNA (NTC), day3


title: 3A_KRAB_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 12

value: dCas9_DNMT3A_KRAB, non targeted guide RNA (NTC), day3


title: mut3A_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 16

value: dCas9-DNMT3A with R882H mutation , non targeted guide RNA (NTC), day3


title: MSssI_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 4

value: dCas9_M.SssI, BACH2 targeted guide RNA8 ,day3


title: IP-GFP, puromycin, replicate B

description:
Library name: Sample 20
Column name in Raw_Counts_All.txt: gfp_puro_B2

value: puromycin


title: CRISPRoff_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 8

value: DNMT3A_DNMT3L_dCas9_BFP_KRAB, BACH2 targeted guide RNA8 ,day3


title: 3A3A_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 1

value: epithelial-like cell

value: dCas9_DNMT3A_DNMT3A, BACH2 targeted guide RNA8 ,day3


title: mut3A_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 7

value: dCas9-DNMT3A with R882H mutation , BACH2 targeted guide RNA8 ,day3


title: 3A_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 6

value: dCas9_DNMT3A, BACH2 targeted guide RNA8 ,day3


title: IP-GFP, untreated, replicate A

description:
Library name: Sample 17
Column name in Raw_Counts_All.txt: gfp_un_A1

value: untreated


title: IP-CTL, puromycin+CB-6644, replicate 1

description:
Library name: Sample 15
Column name in Raw_Counts_All.txt: vide_CB-6644_puro_1

value: RUVBL1 GFP-knock-in


title: IP-CTL, puromycin+CB-6644, replicate 2

description:
Library name: Sample 16
Column name in Raw_Counts_All.txt: vide_CB-6644_puro_2


title: IP-GFP, puromycin+CB-6644, replicate 2

description:
Library name: Sample 14
Column name in Raw_Counts_All.txt: GFP_CB-6644_puro_2


title: dDNMT3A_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 9

value: dCas9_dDNMT3A, BACH2 targeted guide RNA8 ,day3


title: 3A3L_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 2

value: dCas9_DNMT3A_DNMT3L, BACH2 targeted guide RNA8 ,day3


title: IP-CTL, CB-6644, replicate 2

description:
Library name: Sample 12
Column name in Raw_Counts_All.txt: vide_CB-6644_2


title: IP-CTL, puromycin, replicate A

description:
Library name: Sample 23
Column name in Raw_Counts_All.txt: vide_puro_A4

value: RPAP3 GFP-knock-in


title: SunTag_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 5

value: dCas9_SunTag_scFv GCN4_DNMT3A, BACH2 targeted guide RNA8 ,day3


title: IP-CTL, puromycin, replicate B

description:
Library name: Sample 24
Column name in Raw_Counts_All.txt: vide_puro_B4

value: immmunoprecipitated mRNA using uncoupled beads


title: 3A_KRAB_BACH2_g8_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 3

value: dCas9_DNMT3A_KRAB, BACH2 targeted guide RNA8 ,day3


title: 3A3A_NTC_3d (RNA-Seq)

description: Library name: Total RNAseq_Sample 10

value: dCas9_DNMT3A_DNMT3A, non targeted guide RNA (NTC), day3


title: IP-CTL, untreated, replicate 2

description:
Library name: Sample 6
Column name in Raw_Counts_All.txt: vide_untreated_2


title: IP-CTL, untreated, replicate A

description:
Library name: Sample 21
Column name in Raw_Counts_All.txt: vide_un_A3


title: IP-GFP, puromycin, replicate 2

description:
Library name: Sample 4
Column name in Raw_Counts_All.txt: GFP_Puro_2

value: immmunoprecipitated mRNA using beads coupled to anti-GFP


title: IP-GFP, puromycin, replicate A

description:
Library name: Sample 19
Column name in Raw_Counts_All.txt: gfp_puro_A2


title: IP-GFP, untreated, replicate 2

description:
Library name: Sample 2
Column name in Raw_Counts_All.txt: GFP_untreated_2


title: IP-GFP, CB-6644, replicate 2

description:
Library name: Sample 10
Column name in Raw_Counts_All.txt: GFP_CB-6644_2


title: IP-GFP, puromycin, replicate 1

description:
Library name: Sample 3
Column name in Raw_Counts_All.txt: GFP_Puro_1


title: HMC3 BLEODMY02

city: Shanghai

first: Yu

last: Sun

address: 320 Yueyang Rd, Life Sciences Building A #1508

department: Shanghai Institute of Nutrition and Health

country: China

institute: Chinese Academy of Sciences

description:
PE150 high throughout data
BLEODMY_vs_BLEO.deseq2.annotation (HMC3)
Sample 8 (BLEO/DMY)

data_processing:
Illumina Casava1.7 software used for basecalling.
Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence, then mapped to human whole genome (UCSC GRCh38/hg38) using bowtie v0.12.2 with parameters -q -p 4 -e 100 -y -a -m 10 --best --strata.
Reads Per Kilobase of exon per Megabase of library size (RPKM) were calculated using a protocol from Chepelev et al., Nucleic Acids Research, 2009. In short, exons from all isoforms of a gene were merged to create one meta-transcript. The number of reads falling in the exons of this meta-transcript were counted and normalized by the size of the meta-transcript and by the size of the library.
Assembly: GRCh38/hg38
Supplementary files format and content: counts, tpm

source_name: Human brain

growth_protocol: Human microglial cell line (HMC3) was routinely cultured in DMEM media supplemented with 10% FBS, until a total number of approximately 1,000,000 was reached in each flask and subject to treatment by the chemotherapeutic agent bleomycin (BLEO) at 50 μg/ml and/or DMY at 100 μM, individually.

extract_protocol:
Cells from both culture conditions were lysed for RNA preparation using Trizol reagent. Illumina TruSeq RNA Sample Prep Kit (Cat#FC-122-1001) was used with 1 μg of total RNA for the construction of sequencing libraries.
RNA libraries were prepared for sequencing using standard Illumina protocols.

treatment_protocol: To induce senescence, bleomycin (BLEO) was added to the media at 50 μg/ml, and cells were treated for 12 h before media change. Cells were allowed to stay in culture with appropriate media change until 7-10 days later when they were exposed to DMY at 100 μM for 2-3 days, then lysed or immediately collected for lysis.

value: Human brain

value: Human HMC3 microglia

value: Stromal

value: Bleomycin/Dihydromyricetin


title: HMC3 BLEO02

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 5 (BLEO)

value: Bleomycin


title: MITDMY02

description: Library name: Sample 8

data_processing:
Illumina Casava1.7 software used for basecalling.
Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence, then mapped to GRCh38/hg38 whole genome using bowtie v0.12.2 with parameters -q -p 4 -e 100 -y -a -m 10 --best --strata
Reads Per Kilobase of exon per Megabase of library size (RPKM) were calculated using a protocol from Chepelev et al., Nucleic Acids Research, 2009. In short, exons from all isoforms of a gene were merged to create one meta-transcript. The number of reads falling in the exons of this meta-transcript were counted and normalized by the size of the meta-transcript and by the size of the library.
Assembly: GRCh38/hg38
Supplementary files format and content: tab-delimited text files include FPKM values for each sample.
Supplementary files format and content: Matrix table with raw gene counts for every gene and every sample.

source_name: Prostate

growth_protocol: Normal human prostate-derived stromal cells (PSC27) were routinely cultured in stromal complete media supplemented with 10% FBS. For mouse in vivo implantation, a total number of approximately 250,000 was reached and subject to in vitro combination with human prostate cancer cells (PC3, at the number of 1,000,000). After xenografting of cell mixtures to the hind flank of animals, the chemotherapeutic agent mitoxantrone (MIT) and/or the senomorphic compound DMY was administered biweekly from the 3rd week post implantation.

extract_protocol:
Stromal cells were specifically isolated via laser capture microdissection (LCM) of histologically stained (hematoxylin) mouse tumor sections before lysed for RNA preparation. Illumina TruSeq RNA Sample Prep Kit (Cat#FC-122-1001) was used with 1 μg of total amplified RNA for the construction of sequencing libraries per sample.
RNA libraries were prepared for sequencing using standard Illumina protocols. Three independent libraries were generated from 3 individual samples per treatment group.

treatment_protocol: Animals were treated by MIT (0.2 mg/kg) alone or MIT plus DMY (20 mg/kg) (dissolved in ethanol: polyethylene glycol 400: Phosal 50 PG at 10:30:60). Agents were delivered intraperitoneally (i.p.) once every 2 weeks starting from the beginning of the 3rd week, with a total number of 3 biweek cycles throughout the whole regimen (8-weeks).

value: Prostate

value: Normal human primary prostate stromal cell

value: Wildtype

value: Mitoxantrone/DMY

value: Day 56


title: IP-GFP, puromycin+CB-6644, replicate 1

description:
Library name: Sample 13
Column name in Raw_Counts_All.txt: GFP_CB-6644_puro_1

value: RUVBL1 GFP-knock-in


title: IP-GFP, untreated, replicate 1

description:
Library name: Sample 1
Column name in Raw_Counts_All.txt: GFP_untreated_1

value: untreated


title: RNAseq_2106363_Erlotinib_EGF_4hr3

data_processing:
Quality control filtering and adapter trimming of fastq files was performed with trim_galore
Paired-end reads were mapped by STAR(v2.7.1a) using parameters "-c -p 4 --outFilterType BySJout --outFilterMultimapNmax 20 --alignSJoverhangMin 8 --alignSJstitchMismatchNmax 5 -1 5 5 --alignSJDBoverhangMin 10 --outFilterMismatchNmax 999 --outFilterMismatchNoverReadLmax 0.04 --alignIntronMin 20 --alignIntronMax 100000 --alignMatesGapMax 100000 --outSAMmapqUnique 60 --outSAMmultNmax 1 --outSAMstrandField intronMotif --outSAMattributes NH HI AS nM NM MD --outSAMunmapped Within --outSAMtype BAM SortedByCoordinate --outReadsUnmapped None --chimJunctionOverhangMin 12 --chimSegmentReadGapMax 3 --chimMultimapNmax 10 --chimMultimapScoreRange 10 --chimNonchimScoreDropMin 10 --chimOutJunctionFormat 1 --quantMode TranscriptomeSAM GeneCounts --twopassMode Basic --peOverlapNbasesMin 12 --peOverlapMMp 0.1 --outWigType wiggle --outWigStrand Stranded --outWigNorm RPM"
Read duplication was marked with MarkDuplicates from GATK (v4.0.4.0)
RSEM was used to quantify read counts per gene
Assembly: hg38 (GRCh38.p12)
Supplementary files format and content: gene-based raw counts, FPKM and TPM normalized txt files

source_name: Rhabdomyosarcoma (RD) cells

growth_protocol: DMEM + 10% FBS + Pen/Strep+ Glutamine (complete media); DMEM+0.1% BSA+Pen/Strep+Glutamine (serum starvation media)

extract_protocol:
RNA was extracted using Qiagen RNeasy kit
Library was constructed using standard Illumina protocols

treatment_protocol: Cells were treated with Erlotinib and serum starved in serum starvation media for 24 hr and then treated with 100ng/ml EGF for indicated time points.

value: Rhabdomyosarcoma (RD) cells [ATCC CCL-136]

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644) treated cells 4hr


title: RNAseq_2106361_Erlotinib_EGF_4hr1


title: RNAseq_2106355_Erlotinib_EGF_1hr1

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644) treated cells 1hr


title: RNAseq_2106360_Erlotinib_EGF_2hr3

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644) treated cells 2hr


title: RNAseq_2106359_Erlotinib_EGF_2hr2


title: HMC3 CTRL02

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 2 (Control)


title: RNAseq_2106354_Erlotinib_EGF_20min3

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644) treated cells 20min


title: RNAseq_2106362_Erlotinib_EGF_4hr2


title: IP-CTL, CB-6644, replicate 1

description:
Library name: Sample 11
Column name in Raw_Counts_All.txt: vide_CB-6644_1

value: immmunoprecipitated mRNA using uncoupled beads


title: IP-CTL, puromycin, replicate 2

description:
Library name: Sample 8
Column name in Raw_Counts_All.txt: vide_Puro_2

value: puromycin


title: IP-CTL, puromycin, replicate 1

description:
Library name: Sample 7
Column name in Raw_Counts_All.txt: vide_Puro_1


title: IP-GFP, CB-6644, replicate 1

description:
Library name: Sample 9
Column name in Raw_Counts_All.txt: GFP_CB-6644_1

value: immmunoprecipitated mRNA using beads coupled to anti-GFP


title: MITDMY03

description: Library name: Sample 9


title: IP-CTL, untreated, replicate 1

description:
Library name: Sample 5
Column name in Raw_Counts_All.txt: vide_untreated_1


title: RNAseq_2106358_Erlotinib_EGF_2hr1


title: MITDMY01

description: Library name: Sample 7


title: HMC3 BLEODMY03

description:
PE150 high throughout data
BLEODMY_vs_BLEO.deseq2.annotation (HMC3)
Sample 9 (BLEO/DMY)

value: Human brain

value: Human HMC3 microglia

value: Stromal

value: Bleomycin/Dihydromyricetin


title: RNAseq_2106348_Erlotinib_UT3

value: Erlotinib (Thermo Fisher) untreated cells T0


title: HMC3 CTRL03

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 3 (Control)


title: HMC3 CTRL01

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 1 (Control)


title: HMC3 BLEO03

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 6 (BLEO)

value: Bleomycin


title: RNAseq_2106343_DMSO_EGF_4hr1

value: DMSO (Sigma) EGF (Sigma E9644) treated cells 4hr


title: RNAseq_2106345_DMSO_EGF_4hr3


title: HMC3 BLEO01

description:
PE150 high throughout data
BLEO_vs_CTRL.deseq2.annotation (HMC3)
Sample 4 (BLEO)


title: RNAseq_2106340_DMSO_EGF_2hr1

value: DMSO (Sigma) EGF (Sigma E9644) treated cells 2hr


title: RNAseq_2106356_Erlotinib_EGF_1hr2


title: RNAseq_2106352_Erlotinib_EGF_20min1


title: RNAseq_2106337_DMSO_EGF_1hr1

value: DMSO (Sigma) EGF (Sigma E9644) treated cells 1hr


title: RNAseq_2106357_Erlotinib_EGF_1hr3

value: Rhabdomyosarcoma (RD) cells [ATCC CCL-136]


title: RNAseq_2106353_Erlotinib_EGF_20min2


title: RNAseq_2106334_DMSO_EGF_20min1

value: DMSO (Sigma) EGF (Sigma E9644) treated cells 20min


title: RNAseq_2106333_DMSO_EGF_10min3

value: DMSO (Sigma) EGF (Sigma E9644) treated cells 10min


title: RNAseq_2106351_Erlotinib_EGF_10min3

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644) treated cells 10min


title: RNAseq_2106344_DMSO_EGF_4hr2


title: RNAseq_2106332_DMSO_EGF_10min2


title: RNAseq_2106346_Erlotinib_UT1


title: RNAseq_2106349_Erlotinib_EGF_10min1


title: RNAseq_2106350_Erlotinib_EGF_10min2


title: RNAseq_2106331_DMSO_EGF_10min1


title: ChIPseq_2281759_ChIP03_Erlotinib_EGF_Input

data_processing:
Raw reads in fastq format were processed with Trim-Galore tool (v0.4.4)
Reads were mapped to human reference genome (GRCh38.p12) with bwa aln, followed by bwa samse7 (v0.7.12-r1039) with -K flag set to 10000000. Samples with Drosophila melanogaster spike-in (BRD4 ChIP-seq) were mapped the the human-fly hybrid genome instead, and reads mapping to human reference were further extracted.
Duplicated reads were marked with bamsormadup tool from biobambam2 (v2.0.87) and Cross-Correlation analysis was conducted with SPP (v1.11)
Assembly: hg38 (GRCh38.p12), dm6
Supplementary files format and content: bigwig

extract_protocol:
Chromatin was immunoprecipitated using the standard protocol and purified using phenol-chloroform extraction on on MaxTract high density columns. Samples (ChIP02 and ChIP03) were spiked-in with Drosophila melanogaster genome.
Libraries were constructed using standard Illumina protocols

tag: spike in

value: drosophila melanogaster

value: Erlotinib (Thermo Fisher) EGF (Sigma E9644)


title: RNAseq_2106347_Erlotinib_UT2


title: RNAseq_2106341_DMSO_EGF_2hr2


title: ChIPseq_2281756_ChIP03_DMSO_Input

value: DMSO (Sigma)


title: ChIPseq_2281757_ChIP03_EGF_Input

value: DMSO (Sigma) EGF (Sigma E9644) treated cells


title: RNAseq_2106338_DMSO_EGF_1hr2


title: RNAseq_2106342_DMSO_EGF_2hr3


title: RNAseq_2106339_DMSO_EGF_1hr3


title: ChIPseq_2281753_ChIP03_EGF_pEGFR_CS

value: Anti-pEGFR  (Y845) (D63B4) (Cell Signalling #6963S)


title: ChIPseq_2281752_ChIP03_DMSO_pEGFR_CS


title: RNAseq_2106335_DMSO_EGF_20min2


title: ChIPseq_2281751_ChIP03_Erlotinib_EGF_pY1

value: RNA Pol II CTD phospho Tyr1 antibody (Active Motif# 61383)


title: ChIPseq_2281750_ChIP03_Erlotinib_pY1

value: Erlotinib (Thermo Fisher)


title: RNAseq_2106336_DMSO_EGF_20min3


title: ChIPseq_2250354_ChIP02_EGF_Input


title: RNAseq_2106330_DMSO_UT_3

value: DMSO (Sigma) untreated cells T0


title: ChIPseq_2281758_ChIP03_Erlotinib_Input


title: RNAseq_2106329_DMSO_UT_2


title: RNAseq_2106328_DMSO_UT_1


title: ChIPseq_2250351_ChIP02_Erlotinib_pEGFR_Ab

value: Anti-pEGFR  (Y1068) (EP774Y) (Abcam #ab40815)


title: ChIPseq_2250347_ChIP02_Erlotinib_pEGFR_CS


title: ChIPseq_2250346_ChIP02_EGF_pEGFR_CS


title: ChIPseq_2281754_ChIP03_Erlotinib_pEGFR_CS


title: HMC3 BLEODMY01

description:
PE150 high throughout data
BLEODMY_vs_BLEO.deseq2.annotation (HMC3)
Sample 7 (BLEO/DMY)

value: Human brain

value: Human HMC3 microglia

value: Stromal

value: Bleomycin/Dihydromyricetin


title: ChIPseq_2281749_ChIP03_EGF_pY1

value: Rhabdomyosarcoma (RD) cells [ATCC CCL-136]


title: ChIPseq_2230563_Erlotinib_EGF_pY1


title: ChIPseq_2230564_Erlotinib_EGF_pEGFR_Abcm


title: ChIPseq_2281748_ChIP03_DMSO_pY1


title: ChIPseq_2250344_ChIP02_Erlotinib_EGF_pY1


title: ChIPseq_2250356_ChIP02_Erlotinib_EGF_Input


title: ChIPseq_2250353_ChIP02_DMSO_Input


title: ChIPseq_2281755_ChIP03_Erlotinib_EGF_pEGFR_CS


title: ChIPseq_2250352_ChIP02_Erlotinib_EGF_pEGFR_Ab


title: ChIPseq_2250348_ChIP02_Erlotinib_EGF_pEGFR_CS


title: ChIPseq_2250350_ChIP02_EGF_pEGFR_Ab


title: ChIPseq_2250355_ChIP02_Erlotinib_Input


title: ChIPseq_2250349_ChIP02_DMSO_pEGFR_Ab


title: ChIPseq_2230557_Erlotinib_IgG

value: Rabbit IgG, Control Antibody (Vector Laboratories #1-1001)


title: ChIPseq_2250343_ChIP02_Erlotinib_pY1


title: ChIPseq_2250342_ChIP02_EGF_pY1


title: ChIPseq_2230551_EGF_Input


title: ChIPseq_2250341_ChIP02_DMSO_pY1


title: ChIPseq_2230565_Erlotinib_EGF_pEGFR_CS


title: ChIPseq_2230560_Erlotinib_pEGFR_CS


title: ChIPseq_2230559_Erlotinib_pEGFR_Abcm


title: ChIPseq_2230562_Erlotinib_EGF_IgG


title: ChIPseq_2230555_EGF_pEGFR_CS


title: ChIPseq_2230561_Erlotinib_EGF_Input


title: ChIPseq_2230549_DMSO_pEGFR_Abcm


title: ChIPseq_2230556_Erlotinib_Input


title: ChIPseq_2230558_Erlotinib_pY1


title: ChIPseq_2230547_DMSO_IgG


title: ChIPseq_2230546_DMSO_Input


title: SJNPC042536_203496240054_R04C01

description:
203496240054_R04C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells

tag: age

tag: Sex

value: male

tag: group

value: cancer survivor

tag: age at cancer diagnosis

tag: diagnostic group

value: Carcinoma

tag: average dose to whole heart, cgy

tag: race group

value: Black


title: ChIPseq_2230553_EGF_pY1

tag: cell type

value: DMSO (Sigma) EGF (Sigma E9644) treated cells


title: SJGCT041998_203496240054_R06C01

description:
203496240054_R06C01
blood from survivor of childhood cancer and control

value: female

value: Germ cell tumor

value: White

tag: base line visit start date

tag: base line visit finish

tag: age at death


title: SJCML042516_203496240054_R02C01

description:
203496240054_R02C01
blood from survivor of childhood cancer and control

tag: tissue

value: Chronic myeloid leukemia


title: ChIPseq_2230554_EGF_pEGFR_Abcm

tag: chip antibody

value: Anti-pEGFR  (Y1068) (EP774Y) (Abcam #ab40815)

tag: treatment


title: SJGCT042505_203496240054_R01C01

description:
203496240054_R01C01
blood from survivor of childhood cancer and control


title: ChIPseq_2230552_EGF_IgG


title: SJHL042036_203496240053_R07C01

description:
203496240053_R07C01
blood from survivor of childhood cancer and control

value: Hodgkin lymphoma


title: SJWLM042138_203496240054_R07C01

description:
203496240054_R07C01
blood from survivor of childhood cancer and control

value: Wilms tumor


title: SJNHL010139_203496240053_R08C01

description:
203496240053_R08C01
blood from survivor of childhood cancer and control

value: Non-Hodgkin lymphoma


title: ChIPseq_2230550_DMSO_pEGFR_CS

value: Anti-pEGFR  (Y845) (D63B4) (Cell Signalling #6963S)

value: DMSO (Sigma)


title: SJALL041887_203496240053_R06C01

description:
203496240053_R06C01
blood from survivor of childhood cancer and control

value: Acute lymphoblastic leukemia


title: SJHL042526_203496240054_R03C01

description:
203496240054_R03C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells


title: SJALL042619_203496240053_R05C01

description:
203496240053_R05C01
blood from survivor of childhood cancer and control


title: SJALL042535_203496240053_R04C01

description:
203496240053_R04C01
blood from survivor of childhood cancer and control


title: SJALL041869_203496240041_R06C01

description:
203496240041_R06C01
blood from survivor of childhood cancer and control


title: SJCA041980_203496240041_R08C01

description:
203496240041_R08C01
blood from survivor of childhood cancer and control


title: SJALL041877_203496240054_R05C01

description:
203496240054_R05C01
blood from survivor of childhood cancer and control

value: male


title: SJHL042525_203496240053_R03C01

description:
203496240053_R03C01
blood from survivor of childhood cancer and control

value: cancer survivor


title: ChIPseq_2230548_DMSO_pY1

value: Rhabdomyosarcoma (RD) cells [ATCC CCL-136]

value: RNA Pol II CTD phospho Tyr1 antibody (Active Motif# 61383)


title: SJNBL042524_203496240041_R03C01

description:
203496240041_R03C01
blood from survivor of childhood cancer and control

value: Neuroblastoma


title: SJALL042504_203496240053_R01C01

description:
203496240053_R01C01
blood from survivor of childhood cancer and control

value: female


title: SJMEL042515_203496240041_R02C01

description:
203496240041_R02C01
blood from survivor of childhood cancer and control

value: Melanoma


title: SJOS042103_203496240041_R07C01

description:
203496240041_R07C01
blood from survivor of childhood cancer and control

value: Osteosarcoma

value: White


title: SJCNS041933_203496240035_R08C01

description:
203496240035_R08C01
blood from survivor of childhood cancer and control

value: Central nervous system (CNS)


title: SJEWS041499_203496240053_R02C01

description:
203496240053_R02C01
blood from survivor of childhood cancer and control

value: Ewing sarcoma family of tumors


title: SJCNS042534_203496240041_R04C01

description:
203496240041_R04C01
blood from survivor of childhood cancer and control


title: SJWLM042533_203496240035_R04C01

description:
203496240035_R04C01
blood from survivor of childhood cancer and control

value: Wilms tumor

value: Black


title: SJRHB042523_203496240035_R03C01

description:
203496240035_R03C01
blood from survivor of childhood cancer and control

value: Rhabdomyosarcoma


title: SJALL041860_203496240035_R07C01

description:
203496240035_R07C01
blood from survivor of childhood cancer and control


title: SJWLM042502_203496240035_R01C01

description:
203496240035_R01C01
blood from survivor of childhood cancer and control


title: SJHL041568_203496240034_R04C01

description:
203496240034_R04C01
blood from survivor of childhood cancer and control

value: Hodgkin lymphoma


title: SJALL004189_203496240034_R08C01

description:
203496240034_R08C01
blood from survivor of childhood cancer and control

value: Acute lymphoblastic leukemia


title: SJALL041853_203496240034_R07C01

description:
203496240034_R07C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells


title: SJALL042503_203496240041_R01C01

description:
203496240041_R01C01
blood from survivor of childhood cancer and control


title: SJALL042546_203496240035_R05C01

description:
203496240035_R05C01
blood from survivor of childhood cancer and control


title: ChIPseq_2250345_ChIP02_DMSO_pEGFR_CS

value: drosophila melanogaster

value: Anti-pEGFR  (Y845) (D63B4) (Cell Signalling #6963S)

value: DMSO (Sigma)


title: SJCNS042501_203496240034_R01C01

description:
203496240034_R01C01
blood from survivor of childhood cancer and control

value: cancer survivor


title: SJCA042494_203537580089_R07C01

description:
203537580089_R07C01
blood from survivor of childhood cancer and control

value: Carcinoma


title: SJRHB042119_203496240035_R06C01

description:
203496240035_R06C01
blood from survivor of childhood cancer and control

value: female


title: SJNHL041616_203537580089_R02C01

description:
203537580089_R02C01
blood from survivor of childhood cancer and control

value: male

value: Non-Hodgkin lymphoma


title: SJRHB041675_203537580089_R01C01

description:
203537580089_R01C01
blood from survivor of childhood cancer and control

value: White


title: SJRHB041677_203537580089_R03C01

description:
203537580089_R03C01
blood from survivor of childhood cancer and control


title: SJOS042616_203496240035_R02C01

description:
203496240035_R02C01
blood from survivor of childhood cancer and control

value: Osteosarcoma


title: SJALL041395_203496240034_R05C01

description:
203496240034_R05C01
blood from survivor of childhood cancer and control


title: SJALL041881_203496240034_R06C01

description:
203496240034_R06C01
blood from survivor of childhood cancer and control


title: SJHL042522_203496240034_R03C01

description:
203496240034_R03C01
blood from survivor of childhood cancer and control


title: SJOS042514_203496240034_R02C01

description:
203496240034_R02C01
blood from survivor of childhood cancer and control


title: SJALL042547_203496240041_R05C01

description:
203496240041_R05C01
blood from survivor of childhood cancer and control


title: SJNHL041625_203504430058_R02C01

description:
203504430058_R02C01
blood from survivor of childhood cancer and control


title: SJAML042478_203504430058_R06C01

description:
203504430058_R06C01
blood from survivor of childhood cancer and control

value: Acute myeloid leukemia


title: SJALL042480_203537580089_R06C01

description:
203537580089_R06C01
blood from survivor of childhood cancer and control


title: SJHL042469_203537580089_R05C01

description:
203537580089_R05C01
blood from survivor of childhood cancer and control


title: SJRHB042500_203508790045_R08C01

description:
203508790045_R08C01
blood from survivor of childhood cancer and control


title: SJHL041566_203537580089_R04C01

description:
203537580089_R04C01
blood from survivor of childhood cancer and control


title: SJCNS042493_203508790045_R07C01

description:
203508790045_R07C01
blood from survivor of childhood cancer and control

value: Central nervous system (CNS)


title: SJOS042491_203504430043_R07C01

description:
203504430043_R07C01
blood from survivor of childhood cancer and control


title: SJALL042466_203504430043_R05C01

description:
203504430043_R05C01
blood from survivor of childhood cancer and control


title: SJALL042477_203504430043_R06C01

description:
203504430043_R06C01
blood from survivor of childhood cancer and control


title: SJNHL041611_203508790045_R04C01

description:
203508790045_R04C01
blood from survivor of childhood cancer and control


title: SJALL042479_203508790045_R06C01

description:
203508790045_R06C01
blood from survivor of childhood cancer and control

value: Black


title: SJALL042468_203508790045_R05C01

description:
203508790045_R05C01
blood from survivor of childhood cancer and control


title: SJWLM041703_203508790045_R02C01

description:
203508790045_R02C01
blood from survivor of childhood cancer and control

value: Wilms tumor


title: SJALL041317_203508790045_R01C01

description:
203508790045_R01C01
blood from survivor of childhood cancer and control


title: SJALL042545_203504430058_R08C01

description:
203504430058_R08C01
blood from survivor of childhood cancer and control


title: SJALL042490_203504430033_R07C01

description:
203504430033_R07C01
blood from survivor of childhood cancer and control


title: SJNHL041631_203504430058_R03C01

description:
203504430058_R03C01
blood from survivor of childhood cancer and control


title: SJGCT041523_203508790045_R03C01

description:
203508790045_R03C01
blood from survivor of childhood cancer and control

value: Germ cell tumor


title: SJCNS042492_203504430058_R07C01

description:
203504430058_R07C01
blood from survivor of childhood cancer and control


title: SJRHB042467_203504430058_R05C01

description:
203504430058_R05C01
blood from survivor of childhood cancer and control

value: Rhabdomyosarcoma


title: SJALL041387_203504430058_R04C01

description:
203504430058_R04C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells

value: Acute lymphoblastic leukemia


title: SJHL042476_203504430033_R06C01

description:
203504430033_R06C01
blood from survivor of childhood cancer and control

value: Hodgkin lymphoma


title: SJRHB041676_203504430033_R01C01

description:
203504430033_R01C01
blood from survivor of childhood cancer and control


title: SJNHL041633_203504430033_R03C01

description:
203504430033_R03C01
blood from survivor of childhood cancer and control


title: SJAML041644_203504430043_R03C01

description:
203504430043_R03C01
blood from survivor of childhood cancer and control


title: SJRHB042499_203504430043_R08C01

description:
203504430043_R08C01
blood from survivor of childhood cancer and control


title: SJALL003102_203504430027_R05C01

description:
203504430027_R05C01
blood from survivor of childhood cancer and control


title: SJRHB003948_203504430027_R08C01

description:
203504430027_R08C01
blood from survivor of childhood cancer and control


title: SJALL041450_203504430058_R01C01

description:
203504430058_R01C01
blood from survivor of childhood cancer and control


title: SJNPC041585_203504430043_R02C01

description:
203504430043_R02C01
blood from survivor of childhood cancer and control


title: SJAML041464_203504430043_R04C01

description:
203504430043_R04C01
blood from survivor of childhood cancer and control


title: SJMEL041583_203504430043_R01C01

description:
203504430043_R01C01
blood from survivor of childhood cancer and control

value: Melanoma


title: SJALL042498_203504430033_R08C01

description:
203504430033_R08C01
blood from survivor of childhood cancer and control

value: cancer survivor


title: SJALL003860_203504430033_R05C01

description:
203504430033_R05C01
blood from survivor of childhood cancer and control


title: SJALL042489_203504430027_R07C01

description:
203504430027_R07C01
blood from survivor of childhood cancer and control


title: SJWLM041719_203504430033_R04C01

description:
203504430033_R04C01
blood from survivor of childhood cancer and control


title: SJALL042474_203496250105_R06C01

description:
203496250105_R06C01
blood from survivor of childhood cancer and control


title: SJSTS041691_203496250105_R01C01

description:
203496250105_R01C01
blood from survivor of childhood cancer and control

value: Soft tissue sarcoma


title: SJEWS042614_203496250102_R08C01

description:
203496250102_R08C01
blood from survivor of childhood cancer and control

value: Ewing sarcoma family of tumors


title: SJGCT042475_203504430027_R06C01

description:
203504430027_R06C01
blood from survivor of childhood cancer and control

value: male


title: SJSTS041693_203504430027_R04C01

description:
203504430027_R04C01
blood from survivor of childhood cancer and control


title: SJALL041177_203504430027_R01C01

description:
203504430027_R01C01
blood from survivor of childhood cancer and control


title: SJCA042488_203496250105_R07C01

description:
203496250105_R07C01
blood from survivor of childhood cancer and control

value: female

value: Carcinoma


title: SJRB041674_203504430033_R02C01

description:
203504430033_R02C01
blood from survivor of childhood cancer and control

value: Retinoblastoma

value: White


title: SJHL041569_203504430027_R02C01

description:
203504430027_R02C01
blood from survivor of childhood cancer and control


title: SJNHL041628_203496250105_R04C01

description:
203496250105_R04C01
blood from survivor of childhood cancer and control

value: Non-Hodgkin lymphoma


title: SJHL041564_203504430027_R03C01

description:
203504430027_R03C01
blood from survivor of childhood cancer and control


title: SJHL042615_203496250105_R08C01

description:
203496250105_R08C01
blood from survivor of childhood cancer and control


title: SJRHB042543_203496250105_R05C01

description:
203496250105_R05C01
blood from survivor of childhood cancer and control


title: SJWLM041710_203496250102_R03C01

description:
203496250102_R03C01
blood from survivor of childhood cancer and control


title: SJNHL041615_203496250105_R03C01

description:
203496250105_R03C01
blood from survivor of childhood cancer and control


title: SJGCT041521_203496250105_R02C01

description:
203496250105_R02C01
blood from survivor of childhood cancer and control

value: Black


title: SJALL041428_203496250102_R01C01

description:
203496250102_R01C01
blood from survivor of childhood cancer and control


title: SJALL041321_203496250102_R05C01

description:
203496250102_R05C01
blood from survivor of childhood cancer and control


title: SJALL003104_203496250102_R07C01

description:
203496250102_R07C01
blood from survivor of childhood cancer and control


title: SJWLM041714_203496250102_R02C01

description:
203496250102_R02C01
blood from survivor of childhood cancer and control

value: Wilms tumor


title: SJHL042544_203496250099_R08C01

description:
203496250099_R08C01
blood from survivor of childhood cancer and control


title: SJEWS042485_203496250099_R07C01

description:
203496250099_R07C01
blood from survivor of childhood cancer and control


title: SJOS041641_203496250099_R02C01

description:
203496250099_R02C01
blood from survivor of childhood cancer and control

value: Osteosarcoma


title: SJALL041333_203496250102_R04C01

description:
203496250102_R04C01
blood from survivor of childhood cancer and control


title: SJCA042484_203496250098_R07C01

description:
203496250098_R07C01
blood from survivor of childhood cancer and control


title: SJRHB041682_203496250099_R01C01

description:
203496250099_R01C01
blood from survivor of childhood cancer and control

value: Rhabdomyosarcoma


title: SJALL005303_203496250099_R06C01

description:
203496250099_R06C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells


title: SJEWS041500_203496250099_R04C01

description:
203496250099_R04C01
blood from survivor of childhood cancer and control


title: SJHL042473_203496250102_R06C01

description:
203496250102_R06C01
blood from survivor of childhood cancer and control


title: SJNHL041632_203496250098_R05C01

description:
203496250098_R05C01
blood from survivor of childhood cancer and control


title: SJHL041570_203496250099_R05C01

description:
203496250099_R05C01
blood from survivor of childhood cancer and control


title: SJCNS042549_203496250098_R08C01

description:
203496250098_R08C01
blood from survivor of childhood cancer and control

value: Central nervous system (CNS)


title: SJALL005157_203496250098_R06C01

description:
203496250098_R06C01
blood from survivor of childhood cancer and control

value: Acute lymphoblastic leukemia


title: SJALL041372_203496250098_R02C01

description:
203496250098_R02C01
blood from survivor of childhood cancer and control


title: SJNBL041605_203496250097_R04C01

description:
203496250097_R04C01
blood from survivor of childhood cancer and control

value: Neuroblastoma


title: SJALL041416_203496250098_R04C01

description:
203496250098_R04C01
blood from survivor of childhood cancer and control

value: cancer survivor


title: SJCNS042548_203496250097_R08C01

description:
203496250097_R08C01
blood from survivor of childhood cancer and control


title: SJWLM041718_203496250098_R03C01

description:
203496250098_R03C01
blood from survivor of childhood cancer and control


title: SJCNS042483_203496250097_R07C01

description:
203496250097_R07C01
blood from survivor of childhood cancer and control


title: SJNHL042471_203496250097_R06C01

description:
203496250097_R06C01
blood from survivor of childhood cancer and control


title: SJOS041643_203496250097_R05C01

description:
203496250097_R05C01
blood from survivor of childhood cancer and control


title: SJNHL041619_203496250097_R03C01

description:
203496250097_R03C01
blood from survivor of childhood cancer and control


title: SJGCT041520_203496250099_R03C01

description:
203496250099_R03C01
blood from survivor of childhood cancer and control

value: Germ cell tumor


title: SJRHB041687_203496250098_R01C01

description:
203496250098_R01C01
blood from survivor of childhood cancer and control


title: SJALL041305_203496250097_R01C01

description:
203496250097_R01C01
blood from survivor of childhood cancer and control


title: SJNHL042470_203496250094_R06C01

description:
203496250094_R06C01
blood from survivor of childhood cancer and control


title: SJPGL042495_203496250094_R08C01

description:
203496250094_R08C01
blood from survivor of childhood cancer and control

value: Other malignancy


title: SJRHB041683_203496250094_R04C01

description:
203496250094_R04C01
blood from survivor of childhood cancer and control


title: SJRHB042481_203496250094_R07C01

description:
203496250094_R07C01
blood from survivor of childhood cancer and control

value: Soft tissue sarcoma


title: SJHL041571_203496250097_R02C01

description:
203496250097_R02C01
blood from survivor of childhood cancer and control

value: male

value: Hodgkin lymphoma


title: SJRB041664_203496250043_R04C01

description:
203496250043_R04C01
blood from survivor of childhood cancer and control

value: Retinoblastoma


title: SJRB041663_203496250043_R01C01

description:
203496250043_R01C01
blood from survivor of childhood cancer and control

value: female

value: White


title: SJALL041347_203496250043_R06C01

description:
203496250043_R06C01
blood from survivor of childhood cancer and control


title: SJALL041368_203496250043_R07C01

description:
203496250043_R07C01
blood from survivor of childhood cancer and control


title: SJALL041332_203496250043_R03C01

description:
203496250043_R03C01
blood from survivor of childhood cancer and control


title: SJAML010729_203496250094_R02C01

description:
203496250094_R02C01
blood from survivor of childhood cancer and control

value: Acute myeloid leukemia


title: SJWLM041700_203496250094_R03C01

description:
203496250094_R03C01
blood from survivor of childhood cancer and control

value: Wilms tumor


title: SJCNS041492_203496250012_R08C01

description:
203496250012_R08C01
blood from survivor of childhood cancer and control

value: Black


title: SJCNS041476_203496250012_R07C01

description:
203496250012_R07C01
blood from survivor of childhood cancer and control


title: SJALL041402_203496250012_R05C01

description:
203496250012_R05C01
blood from survivor of childhood cancer and control


title: SJALL041423_203496250012_R06C01

description:
203496250012_R06C01
blood from survivor of childhood cancer and control


title: SJALL041285_203496250043_R02C01

description:
203496250043_R02C01
blood from survivor of childhood cancer and control


title: SJE2A037_203496250012_R04C01

description:
203496250012_R04C01
blood from survivor of childhood cancer and control


title: SJALL041312_203496250012_R03C01

description:
203496250012_R03C01
blood from survivor of childhood cancer and control


title: SJALL041443_203496250094_R01C01

description:
203496250094_R01C01
blood from survivor of childhood cancer and control


title: SJRB041661_203496250011_R07C01

description:
203496250011_R07C01
blood from survivor of childhood cancer and control


title: SJWLM041704_203496250012_R02C01

description:
203496250012_R02C01
blood from survivor of childhood cancer and control


title: SJALL041384_203496250011_R08C01

description:
203496250011_R08C01
blood from survivor of childhood cancer and control


title: SJALL041335_203496250043_R05C01

description:
203496250043_R05C01
blood from survivor of childhood cancer and control


title: SJALL041362_203496250011_R04C01

description:
203496250011_R04C01
blood from survivor of childhood cancer and control


title: SJNHL041618_203496250011_R06C01

description:
203496250011_R06C01
blood from survivor of childhood cancer and control

value: Non-Hodgkin lymphoma


title: SJRB041667_203496250011_R02C01

description:
203496250011_R02C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells


title: SJALL041365_203496250011_R03C01

description:
203496250011_R03C01
blood from survivor of childhood cancer and control


title: SJWLM041721_203496250094_R05C01

description:
203496250094_R05C01
blood from survivor of childhood cancer and control


title: SJNBL041593_203496250005_R06C01

description:
203496250005_R06C01
blood from survivor of childhood cancer and control


title: SJAML041471_203496250005_R08C01

description:
203496250005_R08C01
blood from survivor of childhood cancer and control


title: SJCNS041478_203496250005_R07C01

description:
203496250005_R07C01
blood from survivor of childhood cancer and control

value: Central nervous system (CNS)


title: SJCNS041487_203496250005_R05C01

description:
203496250005_R05C01
blood from survivor of childhood cancer and control


title: SJCNS041475_203273630025_R06C01

description:
203273630025_R06C01
blood from survivor of childhood cancer and control


title: SJALL041434_203273630025_R05C01

description:
203273630025_R05C01
blood from survivor of childhood cancer and control

value: Acute lymphoblastic leukemia


title: SJHL041562_203496250005_R02C01

description:
203496250005_R02C01
blood from survivor of childhood cancer and control


title: SJCNS041483_203273630025_R08C01

description:
203273630025_R08C01
blood from survivor of childhood cancer and control


title: SJALL041269_203496250012_R01C01

description:
203496250012_R01C01
blood from survivor of childhood cancer and control


title: SJALL041319_203496250005_R03C01

description:
203496250005_R03C01
blood from survivor of childhood cancer and control


title: SJALL041327_203496250005_R01C01

description:
203496250005_R01C01
blood from survivor of childhood cancer and control


title: SJALL041290_203273630025_R04C01

description:
203273630025_R04C01
blood from survivor of childhood cancer and control


title: SJNBL041607_203273200157_R06C01

description:
203273200157_R06C01
blood from survivor of childhood cancer and control

value: Neuroblastoma


title: SJALL003098_203273630025_R07C01

description:
203273630025_R07C01
blood from survivor of childhood cancer and control

value: cancer survivor


title: SJHL041574_203273200157_R08C01

description:
203273200157_R08C01
blood from survivor of childhood cancer and control


title: SJALL041406_203273200157_R07C01

description:
203273200157_R07C01
blood from survivor of childhood cancer and control


title: SJALL041377_203273630025_R02C01

description:
203273630025_R02C01
blood from survivor of childhood cancer and control


title: SJRB041652_203273630025_R01C01

description:
203273630025_R01C01
blood from survivor of childhood cancer and control


title: SJNM041634_203496250011_R05C01

description:
203496250011_R05C01
blood from survivor of childhood cancer and control

value: Non-malignancy


title: SJALL041457_203273200157_R05C01

description:
203273200157_R05C01
blood from survivor of childhood cancer and control


title: SJALL041271_203273200157_R04C01

description:
203273200157_R04C01
blood from survivor of childhood cancer and control


title: SJALL041373_203244490177_R06C01

description:
203244490177_R06C01
blood from survivor of childhood cancer and control


title: SJALL041221_203273200157_R02C01

description:
203273200157_R02C01
blood from survivor of childhood cancer and control


title: SJALL041340_203496250011_R01C01

description:
203496250011_R01C01
blood from survivor of childhood cancer and control


title: SJALL041452_203244490177_R04C01

description:
203244490177_R04C01
blood from survivor of childhood cancer and control


title: SJALL041307_203244490177_R08C01

description:
203244490177_R08C01
blood from survivor of childhood cancer and control


title: SJALL041308_203273200157_R03C01

description:
203273200157_R03C01
blood from survivor of childhood cancer and control


title: SJALL041272_203273200157_R01C01

description:
203273200157_R01C01
blood from survivor of childhood cancer and control


title: SJSTS041647_203244490177_R03C01

description:
203244490177_R03C01
blood from survivor of childhood cancer and control

value: Other malignancy


title: SJALL041379_203244490177_R02C01

description:
203244490177_R02C01
blood from survivor of childhood cancer and control


title: SJALL041296_203244490177_R05C01

description:
203244490177_R05C01
blood from survivor of childhood cancer and control


title: SJALL041182_203496250005_R04C01

description:
203496250005_R04C01
blood from survivor of childhood cancer and control


title: SJALL041397_203244490177_R07C01

description:
203244490177_R07C01
blood from survivor of childhood cancer and control


title: SJALL041311_203244490097_R07C01

description:
203244490097_R07C01
blood from survivor of childhood cancer and control


title: SJRB041654_203244490097_R03C01

description:
203244490097_R03C01
blood from survivor of childhood cancer and control


title: SJALL041304_203244490097_R04C01

description:
203244490097_R04C01
blood from survivor of childhood cancer and control


title: SJALL041302_203244490097_R05C01

description:
203244490097_R05C01
blood from survivor of childhood cancer and control


title: SJCNS041491_203244490097_R08C01

description:
203244490097_R08C01
blood from survivor of childhood cancer and control


title: SJALL041331_203244490097_R02C01

description:
203244490097_R02C01
blood from survivor of childhood cancer and control


title: SJALL041291_203244490097_R01C01

description:
203244490097_R01C01
blood from survivor of childhood cancer and control


title: SJALL041456_203244490096_R07C01

description:
203244490096_R07C01
blood from survivor of childhood cancer and control


title: SJALL041344_203244490096_R03C01

description:
203244490096_R03C01
blood from survivor of childhood cancer and control


title: SJRB041670_203244490096_R01C01

description:
203244490096_R01C01
blood from survivor of childhood cancer and control


title: SJCNS041489_203244490068_R08C01

description:
203244490068_R08C01
blood from survivor of childhood cancer and control


title: SJNBL041592_203244490096_R08C01

description:
203244490096_R08C01
blood from survivor of childhood cancer and control


title: SJALL041249_203244490097_R06C01

description:
203244490097_R06C01
blood from survivor of childhood cancer and control


title: SJALL041313_203273630025_R03C01

description:
203273630025_R03C01
blood from survivor of childhood cancer and control


title: SJALL041419_203244490096_R04C01

description:
203244490096_R04C01
blood from survivor of childhood cancer and control


title: SJRHB060_203244490068_R06C01

description:
203244490068_R06C01
blood from survivor of childhood cancer and control

value: Rhabdomyosarcoma


title: SJALL041375_203244490177_R01C01

description:
203244490177_R01C01
blood from survivor of childhood cancer and control


title: SJALL041445_203244490068_R02C01

description:
203244490068_R02C01
blood from survivor of childhood cancer and control

value: male


title: SJALL041448_203244490096_R02C01

description:
203244490096_R02C01
blood from survivor of childhood cancer and control


title: SJALL041459_203244490067_R06C01

description:
203244490067_R06C01
blood from survivor of childhood cancer and control


title: SJHL041545_203244490068_R07C01

description:
203244490068_R07C01
blood from survivor of childhood cancer and control

value: Hodgkin lymphoma


title: SJALL041295_203244490068_R01C01

description:
203244490068_R01C01
blood from survivor of childhood cancer and control


title: SJALL041316_203244490067_R07C01

description:
203244490067_R07C01
blood from survivor of childhood cancer and control


title: SJLGG001208_203244490067_R08C01

description:
203244490067_R08C01
blood from survivor of childhood cancer and control


title: SJALL041356_203244490068_R03C01

description:
203244490068_R03C01
blood from survivor of childhood cancer and control


title: SJALL041432_203244490096_R06C01

description:
203244490096_R06C01
blood from survivor of childhood cancer and control


title: SJRB041665_203244490096_R05C01

description:
203244490096_R05C01
blood from survivor of childhood cancer and control

value: Retinoblastoma


title: SJALL003624_203244490068_R05C01

description:
203244490068_R05C01
blood from survivor of childhood cancer and control


title: SJRHB041690_203239900219_R07C01

description:
203239900219_R07C01
blood from survivor of childhood cancer and control


title: SJALL041294_203244490068_R04C01

description:
203244490068_R04C01
blood from survivor of childhood cancer and control

value: female


title: SJALL041392_203244490067_R02C01

description:
203244490067_R02C01
blood from survivor of childhood cancer and control


title: SJALL041449_203239900219_R08C01

description:
203239900219_R08C01
blood from survivor of childhood cancer and control

value: White


title: SJRB041649_203244490067_R03C01

description:
203244490067_R03C01
blood from survivor of childhood cancer and control


title: SJCNS041493_203244490067_R05C01

description:
203244490067_R05C01
blood from survivor of childhood cancer and control


title: SJRB041657_203239900219_R02C01

description:
203239900219_R02C01
blood from survivor of childhood cancer and control


title: SJWLM041705_203244490067_R01C01

description:
203244490067_R01C01
blood from survivor of childhood cancer and control


title: SJNBL041598_203504430051_R07C01

description:
203504430051_R07C01
blood from survivor of childhood cancer and control


title: SJALL041458_203239900219_R04C01

description:
203239900219_R04C01
blood from survivor of childhood cancer and control


title: SJWLM041708_203239900219_R03C01

description:
203239900219_R03C01
blood from survivor of childhood cancer and control


title: SJALL041374_203239900219_R01C01

description:
203239900219_R01C01
blood from survivor of childhood cancer and control

value: Unknown


title: SJALL041217_203504430051_R05C01

description:
203504430051_R05C01
blood from survivor of childhood cancer and control


title: SJRB041662_203244490067_R04C01

description:
203244490067_R04C01
blood from survivor of childhood cancer and control


title: SJHL041554_203504430051_R03C01

description:
203504430051_R03C01
blood from survivor of childhood cancer and control


title: SJALL041209_203504430051_R06C01

description:
203504430051_R06C01
blood from survivor of childhood cancer and control


title: SJCNS041479_203239900219_R05C01

description:
203239900219_R05C01
blood from survivor of childhood cancer and control


title: SJEWS041508_203504430051_R04C01

description:
203504430051_R04C01
blood from survivor of childhood cancer and control

value: Ewing sarcoma family of tumors


title: SJHL041567_203497730144_R06C01

description:
203497730144_R06C01
blood from survivor of childhood cancer and control


title: SJALL041242_203504430051_R02C01

description:
203504430051_R02C01
blood from survivor of childhood cancer and control


title: SJALL041193_203497730144_R08C01

description:
203497730144_R08C01
blood from survivor of childhood cancer and control


title: SJALL041245_203497730144_R05C01

description:
203497730144_R05C01
blood from survivor of childhood cancer and control


title: SJALL041289_203497730144_R07C01

description:
203497730144_R07C01
blood from survivor of childhood cancer and control


title: SJALL041213_203497730144_R03C01

description:
203497730144_R03C01
blood from survivor of childhood cancer and control


title: SJALL041194_203497730135_R08C01

description:
203497730135_R08C01
blood from survivor of childhood cancer and control

value: Black


title: SJALL041322_203497730144_R04C01

description:
203497730144_R04C01
blood from survivor of childhood cancer and control


title: SJALL041172_203497730144_R01C01

description:
203497730144_R01C01
blood from survivor of childhood cancer and control


title: SJALL041409_203239900219_R06C01

description:
203239900219_R06C01
blood from survivor of childhood cancer and control


title: SJWLM041699_203497730135_R07C01

description:
203497730135_R07C01
blood from survivor of childhood cancer and control

value: Wilms tumor


title: SJALL041309_203497730135_R02C01

description:
203497730135_R02C01
blood from survivor of childhood cancer and control

value: peripheral blood mononuclear cells


title: SJALL041210_203497730135_R05C01

description:
203497730135_R05C01
blood from survivor of childhood cancer and control


title: SJRHB041685_203497730128_R07C01

description:
203497730128_R07C01
blood from survivor of childhood cancer and control


title: SJHL041556_203497730144_R02C01

description:
203497730144_R02C01
blood from survivor of childhood cancer and control


title: SJALL041173_203504430051_R01C01

description:
203504430051_R01C01
blood from survivor of childhood cancer and control


title: SJHL041544_203497730135_R04C01

description:
203497730135_R04C01
blood from survivor of childhood cancer and control


title: SJALL041399_203497730128_R08C01

description:
203497730128_R08C01
blood from survivor of childhood cancer and control


title: SJALL041185_203497730128_R04C01

description:
203497730128_R04C01
blood from survivor of childhood cancer and control


title: SJOS041640_203497730128_R05C01

description:
203497730128_R05C01
blood from survivor of childhood cancer and control

value: Osteosarcoma


title: SJALL041275_203497730128_R03C01

description:
203497730128_R03C01
blood from survivor of childhood cancer and control

value: Acute lymphoblastic leukemia


title: SJALL041446_203497730033_R08C01

description:
203497730033_R08C01
blood from survivor of childhood cancer and control


title: SJALL041293_203497730135_R06C01

description:
203497730135_R06C01
blood from survivor of childhood cancer and control


title: SJALL041181_203497730135_R03C01

description:
203497730135_R03C01
blood from survivor of childhood cancer and control


title: SJALL003449_203497730135_R01C01

description:
203497730135_R01C01
blood from survivor of childhood cancer and control


title: SJHL041533_203497730128_R01C01

description:
203497730128_R01C01
blood from survivor of childhood cancer and control


title: SJALL041195_203497730033_R07C01

description:
203497730033_R07C01
blood from survivor of childhood cancer and control


title: SJSTS041645_203497730033_R04C01

description:
203497730033_R04C01
blood from survivor of childhood cancer and control


title: SJALL041345_203497730033_R06C01

description:
203497730033_R06C01
blood from survivor of childhood cancer and control


title: SJALL041382_203497730019_R08C01

description:
203497730019_R08C01
blood from survivor of childhood cancer and control


title: SJALL041334_203497730033_R05C01

description:
203497730033_R05C01
blood from survivor of childhood cancer and control


title: SJALL041281_203497730128_R06C01

description:
203497730128_R06C01
blood from survivor of childhood cancer and control


title: SJALL041200_203497730033_R02C01

description:
203497730033_R02C01
blood from survivor of childhood cancer and control


title: SJHL041542_203497730033_R01C01

description:
203497730033_R01C01
blood from survivor of childhood cancer and control


title: SJRHB041684_203497730019_R06C01

description:
203497730019_R06C01
blood from survivor of childhood cancer and control


title: SJALL041189_203497730010_R04C01

description:
203497730010_R04C01
blood from survivor of childhood cancer and control


title: SJHL041555_203497730033_R03C01

description:
203497730033_R03C01
blood from survivor of childhood cancer and control


title: SJALL041282_203497730010_R07C01

description:
203497730010_R07C01
blood from survivor of childhood cancer and control


title: SJALL041171_203497730019_R01C01

description:
203497730019_R01C01
blood from survivor of childhood cancer and control


title: SJALL041238_203497730019_R07C01

description:
203497730019_R07C01
blood from survivor of childhood cancer and control


title: SJALL041241_203497730019_R03C01

description:
203497730019_R03C01
blood from survivor of childhood cancer and control


title: SJHL041531_203497730019_R04C01

description:
203497730019_R04C01
blood from survivor of childhood cancer and control


title: SJALL041378_203497730128_R02C01

description:
203497730128_R02C01
blood from survivor of childhood cancer and control


title: SJHL041550_203497730019_R05C01

description:
203497730019_R05C01
blood from survivor of childhood cancer and control


title: SJALL041246_203497730010_R01C01

description:
203497730010_R01C01
blood from survivor of childhood cancer and control


title: SJWLM041695_203497730010_R08C01

description:
203497730010_R08C01
blood from survivor of childhood cancer and control


title: SJHL041538_203497730010_R03C01

description:
203497730010_R03C01
blood from survivor of childhood cancer and control


title: SJEWS041503_203497730010_R02C01

description:
203497730010_R02C01
blood from survivor of childhood cancer and control


title: SJALL041244_203497730006_R06C01

description:
203497730006_R06C01
blood from survivor of childhood cancer and control


title: SJALL041330_203497730019_R02C01

description:
203497730019_R02C01
blood from survivor of childhood cancer and control


title: SJALL041169_203497730006_R08C01

description:
203497730006_R08C01
blood from survivor of childhood cancer and control


title: SJALL041204_203497730006_R07C01

description:
203497730006_R07C01
blood from survivor of childhood cancer and control


title: SJALL041442_203497730010_R06C01

description:
203497730010_R06C01
blood from survivor of childhood cancer and control


title: SJALL041192_203497730006_R05C01

description:
203497730006_R05C01
blood from survivor of childhood cancer and control


title: SJEWS041507_203497730010_R05C01

description:
203497730010_R05C01
blood from survivor of childhood cancer and control


title: SJALL041348_203497730006_R03C01

description:
203497730006_R03C01
blood from survivor of childhood cancer and control


title: SJALL041394_203497730006_R04C01

description:
203497730006_R04C01
blood from survivor of childhood cancer and control


title: SJALL041187_203496250117_R07C01

description:
203496250117_R07C01
blood from survivor of childhood cancer and control


title: SJALL041279_203497730006_R01C01

description:
203497730006_R01C01
blood from survivor of childhood cancer and control


title: SJALL041190_203496250117_R06C01

description:
203496250117_R06C01
blood from survivor of childhood cancer and control


title: SJHL041530_203496250117_R04C01

description:
203496250117_R04C01
blood from survivor of childhood cancer and control


title: SJALL041390_203497730006_R02C01

description:
203497730006_R02C01
blood from survivor of childhood cancer and control


title: SJALL041220_203496250117_R01C01

description:
203496250117_R01C01
blood from survivor of childhood cancer and control


title: SJHL041552_203496250109_R05C01

description:
203496250109_R05C01
blood from survivor of childhood cancer and control


title: SJNBL041599_203496250117_R03C01

description:
203496250117_R03C01
blood from survivor of childhood cancer and control

value: Neuroblastoma


title: SJNHL041609_203496250117_R08C01

description:
203496250117_R08C01
blood from survivor of childhood cancer and control

value: cancer survivor

value: Non-Hodgkin lymphoma


title: SJWLM041702_203496250109_R07C01

description:
203496250109_R07C01
blood from survivor of childhood cancer and control


title: SJHL041553_203496250117_R05C01

description:
203496250117_R05C01
blood from survivor of childhood cancer and control


title: SJALL041231_203496250109_R08C01

description:
203496250109_R08C01
blood from survivor of childhood cancer and control


title: SJHL041547_203496250117_R02C01

description:
203496250117_R02C01
blood from survivor of childhood cancer and control


title: SJHL041546_203496250074_R03C01

description:
203496250074_R03C01
blood from survivor of childhood cancer and control